BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Common Stock Warrants - ECPv6.0.9//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Common Stock Warrants
X-ORIGINAL-URL:https://commonstockwarrants.com
X-WR-CALDESC:Events for Common Stock Warrants
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
TZID:America/Denver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20210314T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20211107T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210706T170000
DTEND;TZID=America/New_York:20210706T170000
DTSTAMP:20260415T182625
CREATED:20210607T124014Z
LAST-MODIFIED:20210607T124021Z
UID:690943-1625590800-1625590800@commonstockwarrants.com
SUMMARY:Notice of Warrant Redemption- END (NYSE: CHPT\, CHPT.WS)
DESCRIPTION:ChargePoint Holdings\, Inc. (the “Company”) hereby gives notice that it is redeeming\, at 5:00 p.m. New York City time on July 6\, 2021 (the “Redemption Date”)\, all of the Company’s outstanding Public Warrants (as defined in the Warrant Agreement) (the “Warrants”) to purchase shares of the Company’s common stock\, $0.0001 par value per share (the “Common Stock”) for a redemption price of $0.01 per Warrant (the “Redemption Price”)\, that were issued under the Warrant Agreement\, dated as of July 25\, 2019 (the “Warrant Agreement”)\, by and between the Company’s predecessor company\, Switchback Energy Acquisition Corporation (“Switchback”)\, and Continental Stock Transfer & Trust Company\, as warrant agent (the “Warrant Agent”)\, as part of the units sold in Switchback’s initial public offering (the “IPO”). Each Warrant entitles the holder thereof to purchase one share of Common Stock for a purchase price of $11.50 per whole share\, subject to adjustment. Any Warrants that remain unexercised at 5:00 p.m. New York City time on the Redemption Date will be void and no longer exercisable and their holders will have no rights with respect to those Warrants\, except to receive the Redemption Price or as otherwise described in this notice for holders who hold their Warrants in “street name.” Warrants to purchase shares of Common Stock that were issued under the Warrant Agreement in private placements simultaneously with the closing of the IPO and the sale of over-allotment units\, as well as in connection with working capital loans made by NGP Switchback\, LLC to Switchback and are still held by the initial holders thereof or their permitted transferees are not subject to this notice of redemption. \n\n\n\nThe Warrants are listed on the New York Stock Exchange under the symbol “CHPT WS” and the Common Stock is listed on the New York Stock Exchange under the symbol “CHPT.” On June 3\, 2021\, the last reported sale price of the Warrants was $14.80 and the last reported sale price of the Common Stock was $26.27 per share. We expect that the New York Stock Exchange will suspend trading in the Warrants prior to the opening of trading on the Redemption Date and that the last day of trading will be the immediately preceding trading day\, which is expected to be July 2\, 2021. \n\n\n\nTERMS OF REDEMPTION; CESSATION OF RIGHTS \n\n\n\nThe rights of the Warrant holders to exercise their Warrants will terminate immediately prior to 5:00 p.m. New York City time on the Redemption Date. At 5:00 p.m. New York City time on the Redemption Date and thereafter\, the Warrants will no longer be exercisable and the holders of unexercised Warrants will have no rights with respect to those Warrants\, except to receive the Redemption Price or as otherwise described in this notice for holders who hold their Warrants in “street name.” We encourage you to consult with your broker\, financial advisor and/or tax advisor to consider whether or not to exercise your Warrants. Note that the act of exercising is VOLUNTARY\, meaning holders must instruct their broker to submit the Warrants for exercise. \n\n\n\nThe Company is exercising this right to redeem the Warrants pursuant to Section 6 of the Warrant Agreement. Pursuant to Section 6.1 of the Warrant Agreement\, the Company has the right to redeem all of the outstanding Warrants if the last sales price of the Common Stock reported has been at least $18.00 per share on each of twenty (20) trading days within the thirty (30) trading-day period ending on the third trading day prior to the date on which a notice of redemption is given. The last sales price of the Common Stock has been at least $18.00 per share on each of twenty (20) trading days within the thirty (30) trading-day period ending on June 1\, 2021 (which is the third trading day prior to the date of this redemption notice). \n\n\n\nEXERCISE PROCEDURE \n\n\n\nWarrant holders have until 5:00 p.m. New York City time on the Redemption Date to exercise their Warrants to purchase shares of Common Stock. Warrants may only be exercised for cash. Each Warrant entitles the holder thereof to purchase one share of Common Stock at a cash price of $11.50 per whole share (the “Exercise Price”). \n\n\n\nPayment of the exercise funds may be made by wire transfer of immediately available funds. Wire instructions will be provided to the Depository Trust Company and will otherwise be provided upon request. \n\n\n\n\n\n\n\nThose who hold their Warrants in “street name” should immediately contact their broker to determine their broker’s procedure for exercising their Warrants since the process to exercise is VOLUNTARY. \n\n\n\nPersons who are holders of record of their Warrants may exercise their Warrants by sending: \n\n\n\n1.  The Warrant Certificate;2.  A fully and properly completed “Election to Purchase” (a form of which is attached hereto as Annex A)\, duly executed and indicating\, among of things\, the number of Warrants being exercised; and3.  The exercise funds via wire transfer\,\n\n\n\nto: \n\n\n\nContinental Stock Transfer & Trust Company \n\n\n\n1 State Street\, 30th Floor \n\n\n\nNew York\, NY 10004 \n\n\n\nAttention: Compliance Department \n\n\n\nTelephone: (212) 509-4000 \n\n\n\nThe method of delivery of the Warrants is at the option and risk of the holder\, but if mail is used\, registered mail properly insured is suggested. \n\n\n\nThe Warrant Certificate\, the fully and properly completed Election to Purchase and the exercise funds must be received by Continental Stock Transfer & Trust Company prior to 5:00 p.m. New York City time on the Redemption Date. Subject to the following paragraph\, any failure to deliver a fully and properly completed Election to Purchase together with the related Warrant Certificate and exercise funds before such time will result in such holder’s Warrants being redeemed at the Redemption Price of $0.01 per Warrant and not exercised. \n\n\n\nFor holders of Warrants who hold their Warrants in “street name\,” provided that the Exercise Price for the Warrants being exercised and a Notice of Guaranteed Delivery and the exercise funds are received by the Warrant Agent prior to 5:00 p.m. New York City time on the Redemption Date\, broker-dealers shall have two business days from the Redemption Date\, or 5:00 p.m. New York City time on July 6\, 2021\, to deliver the Warrants to the Warrant Agent. Any such Warrant received without an Election to Purchase and a Notice of Guaranteed Delivery having been duly executed and fully and properly completed or the exercise funds being submitted will be deemed to have been delivered for redemption at the Redemption Price of $0.01 per Warrant\, and not for exercise. \n\n\n\nPROSPECTUS \n\n\n\nA prospectus covering the shares of Common Stock issuable upon the exercise of the Warrants (and the supplements thereto) is included in a registration statement filed with\, and declared effective by\, the Securities and Exchange Commission (Registration No. 333-253759) (the “SEC”). The SEC also maintains an Internet website that contains a copy of this prospectus. The address of this site is www.sec.report. Alternatively\, to obtain a copy of the prospectus (and the supplements thereto)\, please visit our investor relations website (investors.chargepoint.com). \n\n\n\nREDEMPTION PROCEDURE \n\n\n\nPayment of the Redemption Price will be made by the Company upon presentation and surrender of a Warrant for payment after 5:00 p.m. New York City time on the Redemption Date. Those who hold their shares in “street name” should contact their broker to determine their broker’s procedure for redeeming their Warrants.
URL:https://commonstockwarrants.com/event/notice-of-warrant-redemption-end-nyse-chpt-chpt-ws/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/06/CHPT_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210709T080000
DTEND;TZID=America/New_York:20210709T170000
DTSTAMP:20260415T182625
CREATED:20210710T025400Z
LAST-MODIFIED:20210712T030953Z
UID:691196-1625817600-1625850000@commonstockwarrants.com
SUMMARY:Hims & Hers Announces Redemption of All Outstanding Warrants (NYSE: HIMS\, HIMS.WS) - BEGIN
DESCRIPTION:July 09\, 2021 05:00 PM Eastern Daylight Time \n\n\n\nSAN FRANCISCO–(BUSINESS WIRE)–Hims & Hers Health\, Inc. (“Hims & Hers” or the “Company\,” NYSE: HIMS)\, the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers\, today announced that it will redeem all of its outstanding warrants (the “Warrants”) to purchase shares of the Company’s Class A common stock\, par value $0.0001 per share (the “Common Stock”)\, that were issued under the Warrant Agreement\, dated July 22\, 2019 (the “Warrant Agreement”)\, by and between the Company and Continental Stock Transfer & Trust Company\, as warrant agent (the “Warrant Agent”)\, that remain outstanding at 5:00 p.m. New York City time on August 9\, 2021 (the “Redemption Date”) for a redemption price of $0.10 per Warrant. The Warrants consist of (i) the units sold in the Company’s initial public offering (the “Public Warrants”) and (ii) warrants to purchase shares of Common Stock previously held by Oaktree Acquisition Holdings\, L.P.\, the Company’s sponsor\, that were cancelled and issued or issuable to former stockholders of Hims\, Inc. in connection with the Company’s business combination that closed in January 2021. As previously announced\, in February 2021 all of the outstanding Private Placement Warrants (as defined in the Warrant Agreement) were net exercised. \n\n\n\nUnder the terms of the Warrant Agreement\, the Company is entitled to redeem all of the outstanding Warrants at a redemption price of $0.10 per Warrant if the last sales price (the “Reference Value”) of the Common Stock is at least $10.00 per share on the trading day prior to the date on which a notice of redemption is given. At the direction of the Company\, the Warrant Agent has delivered a notice of redemption to each of the registered holders of the outstanding Warrants. In addition\, the New York Stock Exchange intends to halt trading on the Public Warrants after close of market on August 6. 2021. The redemption will not affect trading of the Company’s Common Stock. \n\n\n\nThe Warrants may be exercised by the holders thereof until 5:00 p.m. New York City time on the Redemption Date to purchase fully paid and non-assessable shares of Common Stock underlying such Warrants. Payment upon exercise of the Warrants may be made either (i) in cash\, at an exercise price of $11.50 per share of Common Stock or (ii) on a “cashless basis” in which the exercising holder will receive 0.267 shares per Warrant\, which is the number of shares of Common Stock determined in accordance with the terms of the Warrant Agreement and based on the Redemption Date\, August 9\, 2021\, and the average last sale price of the Common Stock during the ten (10) trading days ending on the third trading day prior to the date on which the notice of redemption is sent to holders of Warrants\, which was $10.78 (the “Fair Market Value”). If any holder of Warrants would\, after taking into account all of such holder’s Warrants exercised at one time\, be entitled to receive a fractional interest in a share of Common Stock\, the number of shares such holder will be entitled to receive will be rounded down to the nearest whole number of shares. \n\n\n\nAny Warrants that remain unexercised at 5:00 p.m. New York City time on the Redemption Date will be void and no longer exercisable\, and the holders of those Warrants will be entitled to receive only the redemption price of $0.10 per Warrant. \n\n\n\nNone of the Company\, its board of directors or employees has made or is making any representation or recommendation to any holder of the Warrants as to whether to exercise or refrain from exercising any Warrants. \n\n\n\nA registration statement on Form S-1 under the Securities Act of 1933\, as amended\, has been filed with\, and declared effective by\, the Securities and Exchange Commission (Registration No. 333-252814) covering the Common Stock issuable upon exercise of the Warrants. The SEC maintains an Internet website that contains a copy of this prospectus. The address of that site is www.sec.gov. Alternatively\, you can obtain a copy of the prospectus from the Company’s investor relations website at https://investors.forhims.com/. \n\n\n\nQuestions concerning redemption and exercise of the Warrants can be directed to our Warrant Agent\, Continental Stock Transfer & Trust Company\, at 1 State Street 30th Floor\, New York\, NY 10004-1561\, by telephone at (212) 509-4000 or by email at reorg@continentalstock.com \n\n\n\nNo Offer or Solicitation \n\n\n\nThis press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any offer of any of the Company’s securities in any jurisdiction in which such offer\, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. \n\n\n\nForward Looking Statements \n\n\n\nThis press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933\, as amended and Section 21E of the Securities Exchange Act of 1934\, as amended. These forward-looking statements can be identified by the use of forward-looking terminology\, including the word “will\,” or its negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations. Such statements include\, but are not limited to\, expectations regarding the redemption of the Warrants. These statements are based on management’s current expectations\, but actual results may differ materially due to various factors. By their nature\, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. \n\n\n\nThe forward-looking statements contained in this press release are based on our current expectations and beliefs concerning future developments and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks\, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include\, but are not limited to\, risks related to the redemption of the Warrants\, as well as those factors described in the “Risk Factors” section and other sections of our most recent Annual Report on Form 10-K\, most recent Quarterly Report on Form 10-Q and other current and periodic reports we file from time to time. \n\n\n\nShould one or more of these risks or uncertainties materialize\, or should any of our assumptions prove incorrect\, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements\, whether as a result of new information\, future events or otherwise\, except as may be required under applicable securities laws. \n\n\n\nAbout Hims & Hers \n\n\n\nHims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals\, enabling them to access high-quality medical care for numerous conditions related to primary care\, mental health\, sexual health\, dermatology\, and more. Launched in November 2017\, the company also offers thoughtfully created and curated health and wellness products. With products and services available across all 50 states and Washington\, D.C.\, Hims & Hers is able to provide access to quality\, convenient and affordable care for all Americans. Hims & Hers was founded by CEO Andrew Dudum\, Hilary Coles\, Jack Abraham and Joe Spector at venture studio Atomic in San Francisco\, California. For more information about Hims & Hers\, please visit forhims.com and forhers.com. \n\n\n\n\n\n\n\nContacts\n\n\n\nLinda O’Connorpress@forhims.com
URL:https://commonstockwarrants.com/event/hims-hers-announces-redemption-of-all-outstanding-warrants-nyse-hims-hims-ws-begin/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/07/HIMS_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210709T170000
DTEND;TZID=America/New_York:20210709T170000
DTSTAMP:20260415T182625
CREATED:20210610T134239Z
LAST-MODIFIED:20210610T134245Z
UID:690972-1625850000-1625850000@commonstockwarrants.com
SUMMARY:Opendoor Finalizes Redemption of Public Warrants (NSDQ: OPEN\, OPENW) -End
DESCRIPTION:SAN FRANCISCO\, June 09\, 2021 (GLOBE NEWSWIRE) — Opendoor Technologies Inc. (Nasdaq: OPEN)\, (“Opendoor” or “the Company”)\, a leading digital platform for residential real estate\, today announced that the Company will redeem all of its outstanding warrants (the “Public Warrants”) to purchase shares of the Company’s common stock\, par value $0.0001 per share (the “Common Stock”)\, that were issued under the Warrant Agreement\, dated April 27\, 2020\, by and between the Company and Continental Stock Transfer & Trust Company (“CST”)\, as warrant agent\, as amended by the First Amendment to the Warrant Agreement\, dated March 22\, 2021\, by and among the Company\, CST and American Stock Transfer & Trust Company (the “Warrant Agent”)\, as warrant agent (as amended\, the “Warrant Agreement”)\, as part of the units sold in the Company’s initial public offering (the “IPO”) and that remain outstanding at 5:00 p.m. New York City time on July 9\, 2021 (the “Redemption Date”) for a redemption price of $0.10 per Public Warrant. In addition\, the Company will redeem all of its outstanding warrants to purchase Common Stock that were issued under the Warrant Agreement in a private placement simultaneously with the IPO (the “Private Warrants” and\, together with the Public Warrants\, the “Warrants”) on the same terms as the outstanding Public Warrants. \n\n\n\nUnder the terms of the Warrant Agreement\, the Company is entitled to redeem all of the outstanding Public Warrants at a redemption price of $0.10 per Public Warrant if (i) the last sales price (the “Reference Value”) of the Common Stock is at least $10.00 per share on each of twenty trading days within any thirty-day trading period ending on the third trading day prior to the date on which a notice of redemption is given and (ii) if the Reference Value is less than $18.00 per share\, the Private Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants. At the direction of the Company\, the Warrant Agent has delivered a notice of redemption to each of the registered holders of the outstanding Warrants. \n\n\n\nThe Warrants may be exercised by the holders thereof until 5:00 p.m. New York City time on the Redemption Date to purchase fully paid and non-assessable shares of Common Stock underlying such Warrants. As the Reference Value is less than $18.00 per share\, payment upon exercise of the Warrants may be made either (i) in cash\, at an exercise price of $11.50 per share of Common Stock or (ii) on a “cashless basis” in which the exercising holder will receive a number of shares of Common Stock to be determined in accordance with the terms of the Warrant Agreement and based on the Redemption Date and the volume weighted average price (the “Fair Market Value”) of the Common Stock during the 10 trading days immediately following the date on which the notice of redemption is sent to holders of Warrants. The Company will provide holders the Fair Market Value no later than one business day after such 10-trading day period ends. In no event will the number of shares of Common Stock issued in connection with an exercise on a cashless basis exceed 0.361 shares of Common Stock per Warrant. If any holder of Warrants would\, after taking into account all of such holder’s Warrants exercised at one time\, be entitled to receive a fractional interest in a share of Common Stock\, the number of shares the holder will be entitled to receive will be rounded down to the nearest whole number of shares. \n\n\n\nAny Warrants that remain unexercised at 5:00 p.m. New York City time on the Redemption Date will be void and no longer exercisable\, and the holders of those Warrants will be entitled to receive only the redemption price of $0.10 per Warrant. \n\n\n\nNone of the Company\, its board of directors or employees has made or is making any representation or recommendation to any holder of the Warrants as to whether to exercise or refrain from exercising any Warrants. \n\n\n\nThe shares of Common Stock underlying the Warrants have been registered by the Company under the Securities Act of 1933\, as amended\, and are covered by a registration statement filed on Form S-1 with\, and declared effective by\, the Securities and Exchange Commission (Registration No. 333-251529). The SEC maintains an Internet website that contains a copy of this prospectus. The address of that site is www.sec.gov. Alternatively\, you can obtain a copy of the prospectus from the Company’s investor relations website at https://investor.opendoor.com. \n\n\n\nQuestions concerning redemption and exercise of the Warrants can be directed to our information agent\, D.F. King & Co.\, Inc.\, at 48 Wall Street\, 22nd Floor\, New York\, NY 10005\, Attention: Michael Horthman\, telephone number: (800) 578-5378 (toll-free) or (212) 269-5550 (banks and brokers) or email: opendoor@dfking.com. \n\n\n\nNo Offer or Solicitation \n\n\n\nThis press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any offer of any of the Company’s securities in any jurisdiction in which such offer\, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. \n\n\n\nForward Looking Statements \n\n\n\nThis press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995\, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking. These forward-looking statements generally are identified by the words “anticipate\,” “believe\,” “contemplate\,” “continue\,” “could\,” “estimate\,” “expect\,” “forecast”\, “future”\, “intend\,” “may\,” “might”\, “opportunity”\, “plan\,” “possible”\, “potential\,” “predict\,” “project\,” “should\,” “strategy”\, “strive”\, “target\,” “will\,” or “would”\, the negative of these words or other similar terms or expressions. The absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions\, projections and other statements about future events that are based on current expectations and assumptions and\, as a result\, are subject to risks and uncertainties. Many important factors could cause actual future events to differ materially from the forward-looking statements in this press release\, including but not limited to the risks and uncertainties set forth in the Company’s filings with the U.S. Securities and Exchange Commission. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements\, and the Company assumes no obligation and does not intend to update or revise these forward-looking statements\, whether as a result of new information\, future events\, or otherwise. The Company does not give any assurance that it will achieve its expectations. \n\n\n\nAbout Opendoor \n\n\n\nOpendoor’s mission is to empower everyone with the freedom to move. Since 2014\, Opendoor has provided people across the U.S. with a radically simple way to buy\, sell or trade-in a home online. Opendoor currently operates in a growing number of markets across the U.S. \n\n\n\nContact Information \n\n\n\nInvestors:Whitney KukulkaThe Blueshirt Groupinvestors@opendoor.com \n\n\n\nMedia:Sheila Tran / Charles StewartOpendoorpress@opendoor.com
URL:https://commonstockwarrants.com/event/opendoor-finalizes-redemption-of-public-warrants-nsdq-open-openw-end/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/06/OPEN_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210716T080000
DTEND;TZID=America/New_York:20210716T170000
DTSTAMP:20260415T182625
CREATED:20210716T150012Z
LAST-MODIFIED:20210716T150109Z
UID:691301-1626422400-1626454800@commonstockwarrants.com
SUMMARY:Skillz Announces Redemption of Public Warrants (NYSE: SKLZ\, SKLZ.WS)
DESCRIPTION:SAN FRANCISCO–(BUSINESS WIRE)–Skillz Inc. (NYSE: SKLZ) (“Skillz”)\, the leading mobile games platform bringing fair and fun competition to players worldwide\, today announced that it will redeem all of its outstanding public warrants to purchase shares of Skillz’s Class A common stock that were issued under the Warrant Agreement\, dated as of March 5\, 2020 (the “Warrant Agreement”)\, by and among Flying Eagle Acquisition Corp. and Continental Stock Transfer & Trust Company\, as warrant agent and transfer agent (“Continental”)\, and that remain outstanding following 5pm New York City time on August 16\, 2021 for a redemption price of $0.01 per warrant. Warrants that were issued under the Warrant Agreement in a private placement and still held by Eagle Equity Partners II\, LLC\, a Delaware limited liability company\, or its permitted transferees are not subject to this notice of redemption. \n\n\n\nUnder the terms of the Warrant Agreement\, Skillz is entitled to redeem all of such outstanding public warrants if the reported closing price of Skillz’s Class A common stock is at least $18.00 per share on each of 20 trading days within a 30 trading day period. This share price performance requirement was satisfied as of July 13\, 2021. \n\n\n\nContinental\, in its capacity as warrant agent\, has delivered a notice of redemption to each of the registered holders of such outstanding public warrants on behalf of Skillz. \n\n\n\nAll such public warrants may be exercised by the holders thereof until 5pm New York City time on August 16\, 2021\, to purchase fully paid and non-assessable shares of Common Stock underlying such warrants\, at the exercise price of $11.50 per share. \n\n\n\nAny such public warrants that remain unexercised following 5pm New York City time on August 16\, 2021\, will be void and no longer exercisable\, and the holders of those public warrants will be entitled to receive only the redemption price of $0.01 per warrant. \n\n\n\nThe shares of Class A common stock underlying such public warrants have been registered by Skillz under the Securities Act of 1933\, as amended\, and are covered by a registration statement filed on Form S-1 with\, and declared effective by\, the Securities and Exchange Commission (Registration No. 333-252868). \n\n\n\nQuestions concerning redemption and exercise of such public warrants can be directed to: Continental Stock Transfer & Trust Company\, 1 State Street\, 30th Floor\, New York\, NY 10004\, telephone number 212-509-4000. \n\n\n\nFor a copy of the notice of redemption sent to the holders of such public warrants\, please visit the Skillz investor relations website at https://investors.skillz.com/. \n\n\n\nThis press release shall not constitute an offer to sell or the solicitation of an offer to buy any Skillz securities and shall not constitute an offer\, solicitation\, or sale in any jurisdiction in which such offering\, solicitation\, or sale would be unlawful. \n\n\n\nAbout Skillz Inc. \n\n\n\nSkillz is the leading mobile games platform that connects players in fair\, fun\, and meaningful competition. The Skillz platform helps developers build multi-million dollar franchises by enabling social competition in their games. Leveraging its patented technology\, Skillz hosts billions of casual esports tournaments for millions of mobile players worldwide\, and distributes millions in prizes each month. Skillz has earned recognition as one of Fast Company’s Most Innovative Companies\, CNBC’s Disruptor 50\, Forbes’ Next Billion-Dollar Startups\, and the #1 fastest-growing company in America on the Inc. 5000. www.skillz.com \n\n\n\nForward Looking Statements \n\n\n\nThis press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. The Company’s actual results may differ from its expectations\, estimates\, and projections and\, consequently\, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect\,” “estimate\,” “project\,” “budget\,” “forecast\,” “anticipate\,” “intend\,” “plan\,” “may\,” “will\,” “could\,” “should\,” “believes\,” “predicts\,” “potential\,” “continue\,” and similar expressions (or the negative versions of such words or expressions) are intended to identify such forward-looking statements. \n\n\n\nThese forward-looking statements involve significant risks and uncertainties that could cause the Company’s actual results to differ materially from those discussed in the forward-looking statements. Most of these factors are outside of the Company’s control and are difficult to predict. Factors that may cause such differences include\, but are not limited to\, the ability of Skillz to:realize the benefits expected from the business combination; effectively compete in the global entertainment and gaming industries; attract and retain successful relationships with the third party developers that develop and update all of the games hosted on Skillz’s platform; comply with laws and regulations applicable to its business; and as well as other risks and uncertainties indicated from time to time in the Company’s SEC filings\, including those under “Risk Factors” therein\, which are available on the SEC’s website at www.sec.gov. Additional information will be made available in other filings that the Company makes from time to time with the SEC. In addition\, any forward-looking statements contained in this press release are based on assumptions that the Company believes to be reasonable as of this date. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events\, except as required by law.
URL:https://commonstockwarrants.com/event/skillz-announces-redemption-of-public-warrants-nyse-sklz-sklz-ws-2/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/jpeg:https://commonstockwarrants.com/wp-content/uploads/2021/07/SKLZ_Logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210719T170000
DTEND;TZID=America/New_York:20210719T170000
DTSTAMP:20260415T182625
CREATED:20210618T124219Z
LAST-MODIFIED:20210618T125026Z
UID:691033-1626714000-1626714000@commonstockwarrants.com
SUMMARY:Arrival Completing Redemption of Warrants (NASDAQ: ARVL\, ARVLW) - END
DESCRIPTION:LONDON and CHARLOTTE\, N.C.\, June 18\, 2021 (GLOBE NEWSWIRE) — Arrival (the “Company”; Ordinary Shares – NASDAQ: ARVL; CUSIP No. L0423Q 108; Warrants – NASDAQ: ARVLW; CUSIP No. L0423Q 116) announced today that the Company has elected to redeem\, at 5:00 p.m. New York City time on July 19\, 2021 (the “Redemption Date”)\, all of the Company’s outstanding warrants (“Public Warrants”) that were issued under the Warrant Agreement dated as of December 12\, 2019 by and between CIIG Merger Corp. (“CIIG”) and Continental Stock Transfer & Trust Company\, as warrant agent\, as a part of the units sold in CIIG’s initial public offering (“IPO”)\, which Public Warrants were assumed by the Company in connection with the business combination between CIIG\, the Company and ARSNL Merger Sub Inc. \n\n\n\nEach Public Warrant will be redeemed by the Company for $0.01 per Public Warrant (the “Redemption Price”) on the Redemption Date\, unless exercised before 5:00 p.m. on the Redemption Date. The Company is exercising its right to redeem the Public Warrants pursuant to Section 6 of the Warrant Agreement that provides for the right to redeem all of the outstanding Public Warrants if the last reported sales price of the Company’s Ordinary Shares has been at least $18.00 per share on each of 20 trading days within the 30 trading-day period ending on the third business day prior to the date on which a notice of redemption is given. The reported sales price of the Company’s Ordinary Shares has been at least $18.00 per share on each of 20 trading days within the 30-trading day period ending on June 15\, 2021. \n\n\n\nRegistered holders of Public Warrants will have until 5:00 p.m. on July 19\, 2021 to exercise their Public Warrants. Each Public Warrant entitles the holder thereof to purchase one Ordinary Share at a price of $11.50 per Public Warrant exercised (the “Exercise Price”). Any Public Warrants that remain unexercised at 5:00 p.m. New York City time on the Redemption Date will be delisted\, void and no longer exercisable\, and the holders will have no rights with respect to those Public Warrants\, except to receive the Redemption Price. \n\n\n\nAs a result of the redemption\, the Public Warrants will cease to be traded on the NASDAQ effective July 20\, 2021. \n\n\n\nAs of the date hereof\, the Company has 12\,937\,493 Public Warrants outstanding. If all such currently outstanding Public Warrants are exercised prior to the Redemption Date\, the Company will issue an aggregate of 12\,937\,493 Ordinary Shares and receive potential gross exercise proceeds of approximately $148.8 million. \n\n\n\nBeneficial holders desiring to exercise their Public Warrants should contact the brokerage firm holding their Public Warrants immediately to process their exercise and avoid redemption. Brokers will likely have an earlier deadline for beneficial holders to exercise their Public Warrants than the deadline for registered holders set forth above. \n\n\n\nThe Ordinary Shares underlying the Public Warrants have been registered by the Company under the Securities Act of 1933\, as amended\, and are covered by a registration statement filed on Form F 1 with\, and declared effective by\, the Securities and Exchange Commission (Registration No. 333 254885). \n\n\n\nThis release is neither an offer to sell nor a solicitation of an offer to buy any securities of the Company. \n\n\n\nAbout Arrival \n\n\n\nArrival (NASDAQ: ARVL) is reinventing the automotive industry with its entirely new approach to the design and assembly of electric vehicles. Low CapEx\, rapidly scalable Microfactories combined with proprietary in-house developed components\, materials and software\, enable the production of best in class vehicles competitively priced to fossil fuel variants and with a substantially lower total cost of ownership. This transformative approach provides cities globally with the solutions they need to create sustainable urban environments and exceptional experiences for their citizens. Arrival is a global business founded in 2015 and headquartered in London\, UK and Charlotte\, North Carolina\, USA\, with more than 1\,900 global employees located in offices across the United States\, Germany\, the Netherlands\, Israel\, Russia\, and Luxembourg. The company is deploying its first four Microfactories in North Carolina\, USA\, South Carolina\, USA\, Madrid\, Spain\, and Bicester\, UK. \n\n\n\nForward-Looking Statements \n\n\n\nThis press release contains certain forward-looking statements within the meaning of the federal securities laws\, including statements regarding the amount of Ordinary Shares to be issued and the proceeds to be received in connection with the exercise of Public Warrants prior to the Redemption Date. Forward-looking statements are predictions\, projections and other statements about future events that are based on current expectations and assumptions and\, as a result\, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this document\, including\, but not limited to\, a lower number of holders of Ordinary Shares exercising their Public Warrants prior to the Redemption Date. The foregoing list of factors is not exhaustive. Readers are cautioned not to put undue reliance on forward-looking statements\, and Arrival assumes no obligation and does not intend to update or revise these forward-looking statements\, whether as a result of new information\, future events\, or otherwise. Arrival does not give any assurance that Arrival will achieve its expectations.Media Contacts \n\n\n\nMediapr@arrival.com \n\n\n\nInvestorsir@arrival.com
URL:https://commonstockwarrants.com/event/arrival-completing-redemption-of-warrants-nasdaq-arvl-arvlw-end/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/06/ARRIVAL_logo-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210722T080000
DTEND;TZID=America/New_York:20210722T080000
DTSTAMP:20260415T182625
CREATED:20210722T135239Z
LAST-MODIFIED:20210722T135242Z
UID:691406-1626940800-1626940800@commonstockwarrants.com
SUMMARY:Clover Health Investments\, Corp. Announces Redemption of All Outstanding Warrants (NASDAQ: CLOV\, CLOVW) -BEGIN
DESCRIPTION:Clover Health Investments\, Corp. (Nasdaq: CLOV)\, (“Clover Health” or “the Company”)\, an innovative technology company committed to improving health equity for America’s underserved seniors\, today announced that the Company will redeem all of its outstanding warrants (the “Public Warrants”) to purchase shares of the Company’s common stock\, par value $0.0001 per share (the “Common Stock”)\, that were issued under the Warrant Agreement\, dated April 21\, 2020\, by and between the Company and Continental Stock Transfer & Trust Company (the “Warrant Agent”)\, as warrant agent (the “Warrant Agreement”)\, as part of the units sold in the Company’s initial public offering (the “IPO”) and that remain outstanding at 5:00 p.m. New York City time on August 23\, 2021 (the “Redemption Date”) for a redemption price of $0.10 per Public Warrant. In addition\, the Company will redeem all of its outstanding warrants to purchase Common Stock that were issued under the Warrant Agreement in a private placement simultaneously with the IPO (the “Private Warrants” and\, together with the Public Warrants\, the “Warrants”) on the same terms as the outstanding Public Warrants. \n\n\n\nUnder the terms of the Warrant Agreement\, the Company is entitled to redeem all of the outstanding Public Warrants at a redemption price of $0.10 per Public Warrant if (i) the last reported sales price (the “Reference Value”) of the Common Stock is at least $10.00 per share for any twenty trading days within the thirty-day trading period ending on the third trading day prior to the date on which a notice of redemption is given and (ii) if the Reference Value is less than $18.00 per share\, the Private Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants. At the direction of the Company\, the Warrant Agent has delivered a notice of redemption to each of the registered holders of the outstanding Warrants. \n\n\n\nThe Warrants may be exercised by the holders thereof until 5:00 p.m. New York City time on the Redemption Date to purchase fully paid and non-assessable shares of Common Stock underlying such Warrants. As the Reference Value is less than $18.00 per share\, payment upon exercise of the Warrants may be made either (i) in cash\, at an exercise price of $11.50 per share of Common Stock or (ii) on a “cashless basis” in which the exercising holder will receive a number of shares of Common Stock to be determined in accordance with the terms of the Warrant Agreement and based on the Redemption Date and the volume weighted average price (the “Fair Market Value”) of the Common Stock during the 10 trading days immediately following the date on which the notice of redemption is sent to holders of Warrants. The Company will inform holders of the Fair Market Value no later than one business day after such 10-trading day period ends. In no event will the number of shares of Common Stock issued in connection with an exercise on a cashless basis exceed 0.361 shares of Common Stock per Warrant. If any holder of Warrants would\, after taking into account all of such holder’s Warrants exercised at one time\, be entitled to receive a fractional interest in a share of Common Stock\, the number of shares the holder will be entitled to receive will be rounded down to the nearest whole number of shares. \n\n\n\nAny Warrants that remain unexercised at 5:00 p.m. New York City time on the Redemption Date will be void and no longer exercisable\, and the holders of those Warrants will be entitled to receive only the redemption price of $0.10 per Warrant. \n\n\n\n\n\n\n\nNone of the Company\, its board of directors or employees has made or is making any representation or recommendation to any holder of the Warrants as to whether to exercise or refrain from exercising any Warrants. \n\n\n\nThe shares of Common Stock underlying the Warrants have been registered by the Company under the Securities Act of 1933\, as amended\, and are covered by a registration statement filed on Form S-1 with\, and declared effective by\, the Securities and Exchange Commission (Registration No. 333-252073). The SEC maintains an Internet website that contains a copy of this prospectus. The address of that site is www.sec.gov. Alternatively\, you can obtain a copy of the prospectus from the Company’s investor relations website at https://investors.cloverhealth.com. \n\n\n\nQuestions concerning redemption and exercise of the Warrants can be directed to our information agent\, MacKenzie Partners\, Inc.\, at 1407 Broadway\, New York\, NY 10018\, telephone number: (800) 322-2885. \n\n\n\nNo Offer or Solicitation \n\n\n\nThis press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any offer of any of the Company’s securities in any jurisdiction in which such offer\, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. \n\n\n\nForward Looking Statements \n\n\n\nThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933\, as amended\, and Section 21E of the Securities Exchange Act of 1934\, as amended. Forward-looking statements include statements regarding future events. In some cases\, you can identify forward looking statements because they contain words such as “may\,” “will\,” “should\,” “expects\,” “plans\,” “anticipates\,” “going to\,” “can\,” “could\,” “should\,” “would\,” “intends\,” “target\,” “projects\,” “contemplates\,” “believes\,” “estimates\,” “predicts\,” “potential\,” “outlook\,” “forecast\,” “objective\,” “plan\,” “seek\,” “grow\,” “target\,” “if\,” “continue” or the negative of these words or other similar terms or expressions that concern Clover Health’s expectations\, strategy\, priorities\, plans or intentions. These statements are subject to known and unknown risks\, uncertainties and other factors that may cause our actual results to differ materially from results expressed or implied in this press release\, including but not limited to the risks and uncertainties contained in the Risk Factors section of our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31\, 2021. Clover Health assumes no obligation\, and does not intend\, to update these forward-looking statements as a result of future events or developments. \n\n\n\nAbout Clover Health \n\n\n\nClover Health (Nasdaq: CLOV) is a next-generation risk-bearing organization aiming to achieve health equity for all Americans. While our mission is to improve every life\, we particularly focus on seniors who have historically lacked access to affordable high quality healthcare.
URL:https://commonstockwarrants.com/event/clover-health-investments-corp-announces-redemption-of-all-outstanding-warrants-nasdaq-clov-clovw-begin/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/jpeg:https://commonstockwarrants.com/wp-content/uploads/2021/07/CLOV_logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210723T080000
DTEND;TZID=America/New_York:20210723T170000
DTSTAMP:20260415T182625
CREATED:20210723T133824Z
LAST-MODIFIED:20210723T133826Z
UID:691418-1627027200-1627059600@commonstockwarrants.com
SUMMARY:QuantumScape Announces Redemption of Public Warrants (NYSE: QS\, QS.WS) -BEGIN
DESCRIPTION:SAN JOSE\, Calif.–(BUSINESS WIRE)–QuantumScape Corporation (“QuantumScape\,” Class A Common Stock – NYSE: QS; Public Warrants – NYSE: QS.WS) today announced that it has elected to redeem\, at 5:00 p.m. Eastern Daylight Time on August 24\, 2021 (the “Redemption Date”)\, all of QuantumScape’s outstanding public warrants (“Public Warrants”) that were issued under the Warrant Agreement dated as of June 25\, 2020\, as amended on February 13\, 2021 (the “Warrant Agreement”)\, by and between Kensington Capital Acquisition Corp. (“Kensington”) and Continental Stock Transfer & Trust Company\, as warrant agent. The Public Warrants were originally issued in connection with Kensington’s initial public offering in June 2020 (the “IPO”)\, and subsequently assumed by QuantumScape in November 2020 in connection with the business combination by and among Kensington\, Kensington Merger Sub Corp.\, and QuantumScape Battery\, Inc. \n\n\n\nRegistered holders of Public Warrants will have until 5:00 p.m. Eastern Daylight Time on August 24\, 2021 to exercise their Public Warrants. Each Public Warrant entitles the holder thereof to purchase one share of Class A Common Stock at a price of $11.50 per Public Warrant (the “Exercise Price”). Each Public Warrant that remains outstanding as of the Redemption Date will be redeemed by QuantumScape for $0.01 (the “Redemption Price”). Any Public Warrants that remain unexercised at 5:00 p.m. Eastern Daylight Time on the Redemption Date will be delisted\, void and no longer exercisable\, and the holders will have no rights with respect to those Public Warrants\, except to receive the Redemption Price. If a holder of a Public Warrant does not wish for its Public Warrant to be redeemed\, it must exercise such Public Warrant before 5:00 p.m. Eastern Daylight Time on the Redemption Date. \n\n\n\nQuantumScape is exercising its right to redeem the Public Warrants pursuant to Section 6.1 of the Warrant Agreement that provides for the right to redeem all the outstanding Public Warrants if the last reported sales price of QuantumScape’s Class A Common Stock has been at least $18.00 per share on each of 20 trading days within the 30-trading-day period ending on the third business day prior to the date on which a notice of redemption is given. The reported sales price of QuantumScape’s Class A Common Stock has been at least $18.00 per share on each of 20 trading days within the 30-trading-day period ending on July 20\, 2021. \n\n\n\nAs a result of the redemption\, the Public Warrants will cease to be traded on the NYSE effective August 24\, 2021. \n\n\n\nAs of the time of this press release\, QuantumScape has 1\,544\,871 Public Warrants outstanding. If all such currently outstanding Public Warrants are exercised prior to the Redemption Date\, QuantumScape will issue an aggregate of 1\,544\,871 shares of Class A Common Stock and receive potential gross exercise proceeds of approximately $17.8 million. \n\n\n\nWarrants to purchase shares of Class A Common Stock that were issued under the Warrant Agreement in private placements simultaneously with the closing of the IPO\, as well as in connection with working capital loans made by Kensington Capital Sponsor LLC to Kensington (all such warrants\, the “Private Placement Warrants”) are still held by the initial holders or their permitted transferees are not subject to this redemption. However\, QuantumScape is considering the possible redemption of the Private Placement Warrants at a future date in accordance with the terms of the Warrant Agreement. \n\n\n\nNone of QuantumScape\, its board of directors or employees have made or are making any representation or recommendation to any warrant holder as to whether to exercise or refrain from exercising any warrants. \n\n\n\nThe shares of Class A Common Stock underlying the Public Warrants have been registered by QuantumScape under the Securities Act of 1933\, as amended\, and are covered by a registration statement filed on Form S-1 with\, and declared effective by\, the Securities and Exchange Commission (Registration No. 333-251433). \n\n\n\nBeneficial holders desiring to exercise their Public Warrants should contact the brokerage firm holding their Public Warrants immediately to process their exercise to avoid redemption. Brokers will likely have an earlier deadline for beneficial holders to exercise their Public Warrants than the deadline for registered holders set forth above. \n\n\n\nNo Offer or Solicitation \n\n\n\nThis press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any offer of any of QuantumScape’s securities in any jurisdiction in which such offer\, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. \n\n\n\nForward-Looking Statements \n\n\n\nThe information in this press release includes a “forward-looking statement” within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934\, as amended\, including statements regarding the treatment of the Public Warrant\, the number of shares of Class A Common Stock to be issued\, the proceeds to be received in connection with the exercise of Public Warrants prior to the Redemption Date and the Company’s intentions regarding the potential redemption of Private Placement Warrants. \n\n\n\nThese forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside QuantumScape’s control and are difficult to predict\, including\, but not limited to\, fewer than all holders of Public Warrants exercising their Public Warrants prior to the Redemption Date. The foregoing factor is not exhaustive. Readers are cautioned not to put undue reliance on forward-looking statements. Information about other factors that could materially affect QuantumScape is set forth under the “Risk Factors” section in the QuantumScape’s registration statement on Form S-1 filed with the Securities and Exchange Commission on May 17\, 2021\, and available on the SEC’s website at www.sec.gov. \n\n\n\nExcept as otherwise required by applicable law\, QuantumScape disclaims any duty to update any forward-looking statements\, all of which are expressly qualified by the statements in this section\, to reflect events or circumstances after the date of this press release. Should underlying assumptions prove incorrect\, actual results and projections could different materially from those expressed in any forward-looking statements. \n\n\n\nAbout QuantumScape \n\n\n\nQuantumScape is a leader in developing next-generation solid-state lithium-metal batteries for electric vehicles. The company is on a mission to revolutionize energy storage to enable a sustainable future. For more information\, please visit www.quantumscape.com. \n\n\n\n\n\n\n\nContacts\n\n\n\nFor InvestorsJohn Sager\, CFAHead of Investor Relationsir@quantumscape.com \n\n\n\nFor Mediamedia@quantumscape.com
URL:https://commonstockwarrants.com/event/quantumscape-announces-redemption-of-public-warrants-nyse-qs-qs-ws-begin/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/07/QS_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210728T080000
DTEND;TZID=America/New_York:20210728T170000
DTSTAMP:20260415T182625
CREATED:20210728T150518Z
LAST-MODIFIED:20210728T150527Z
UID:691471-1627459200-1627491600@commonstockwarrants.com
SUMMARY:Grid Dynamics Announces Redemption of Public Warrants (Nasdaq: GDYN; GDYNW) -BEGIN
DESCRIPTION:SAN RAMON\, Calif.–(BUSINESS WIRE)–Grid Dynamics Holdings\, Inc. (Nasdaq: GDYN; GDYNW) (“Grid Dynamics”)\, a leader in enterprise-level digital transformation\, today announced that holders of its 2\,773\,141 outstanding public warrants (the “Public Warrants”) to purchase shares of its common stock\, $0.0001 par value per share (the “Common Stock”) will have until 5:00 p.m.\, New York City time\, on August 30\, 2021 (the “Redemption Date”) to exercise their Public Warrants. The Public Warrants are exercisable for an aggregate of 2\,773\,141 shares of Common Stock at a price of $11.50 per share\, representing a total of approximately $31.9 million in potential proceeds to Grid Dynamics. \n\n\n\nPursuant to the terms of the agreements governing the rights of the holders of the Public Warrants\, Grid Dynamics is entitled to redeem all of the outstanding Public Warrants for a redemption price of $0.01 per Public Warrant (the “Redemption Price”) if the last sales price of the Common Stock is at least $18.00 per share on each of twenty (20) trading days within the thirty (30) trading-day period ending on the third trading day prior to the date on which a notice of redemption is given. This share price performance target has been met. Any Public Warrants that remain unexercised immediately after 5:00 p.m.\, New York City time\, on August 30\, 2021 will be void and no longer exercisable\, and the holders of those Public Warrants will be entitled to receive $0.01 per Public Warrant. \n\n\n\nHolders of Public Warrants in “street name” should immediately contact their broker to determine their broker’s procedure for exercising their Public Warrants since the process to exercise is voluntary. Brokers will likely have an earlier deadline for beneficial holders to exercise their Public Warrants than the deadline for registered holders set forth above. If a holder of a Public Warrant does not wish for its Public Warrant to be redeemed\, it must exercise such Public Warrant before 5:00 p.m. New York City time on the Redemption Date. \n\n\n\nThe Public Warrants were issued under the Warrant Agreement\, dated as of October 4\, 2018 (the “Warrant Agreement”)\, by and between Grid Dynamics’ predecessor company\, ChaSerg Technology Acquisition Corp.\, and Continental Stock Transfer & Trust Company\, as warrant agent (the “Warrant Agent”). \n\n\n\nAs a result of the redemption\, the Public Warrants will cease to be traded on the Nasdaq effective August 30\, 2021. \n\n\n\nGrid Dynamics also announced that none of its “Private Placement Warrants” or “Working Capital Warrants” remained outstanding. \n\n\n\nNone of Grid Dynamics\, its board of directors or employees has made or is making any representation or recommendation to any holder of the Public Warrants as to whether to exercise or refrain from exercising any Public Warrants. \n\n\n\nThe shares of Common Stock underlying the Public Warrants have been registered by Grid Dynamics under the Securities Act of 1933\, as amended\, and are covered by a registration statement filed with\, and declared effective by\, the Securities and Exchange Commission (Registration No. 333‑238202). \n\n\n\nQuestions concerning redemption and exercise of the Public Warrants can be directed to Continental Stock Transfer & Trust Company\, 1 State Street\, 30th Floor\, New York\, New York 10004\, Attention: Compliance Department\, telephone number (212) 509-4000. \n\n\n\nNo Offer or Solicitation \n\n\n\nThis press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any offer of any of Grid Dynamics’s securities in any jurisdiction in which such offer\, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. \n\n\n\nAbout Grid Dynamics Holdings\, Inc. \n\n\n\nGrid Dynamics (Nasdaq: GDYN) is a digital-native technology services provider that accelerates growth and bolsters competitive advantage for Fortune 1000 companies. Grid Dynamics provides digital transformation consulting and implementation services in omnichannel customer experience\, big data analytics\, search\, artificial intelligence\, cloud migration\, and application modernization. Grid Dynamics achieves high speed-to-market\, quality\, and efficiency by using technology accelerators\, an agile delivery culture\, and its pool of global engineering talent. Founded in 2006\, Grid Dynamics is headquartered in Silicon Valley with offices across the US\, UK\, Netherlands\, Mexico\, Central\, and Eastern Europe. To learn more about Grid Dynamics\, please visit www.griddynamics.com. \n\n\n\nForward Looking Statements \n\n\n\nThis communication contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that are not historical facts\, and involve risks and uncertainties that could cause actual results of Grid Dynamics to differ materially from those expected and projected. These forward-looking statements can be identified by the use of forward-looking terminology\, including the words “believes\,” “estimates\,” “anticipates\,” “expects\,” “intends\,” “plans\,” “may\,” “will\,” “potential\,” “projects\,” “predicts\,” “continue\,” or “should\,” or\, in each case\, their negative or other variations or comparable terminology. These forward-looking statements include\, without limitation\, statements regarding the redemption of the Public Warrants and the expected proceeds from the exercise of the Public Warrants. \n\n\n\nThese forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside Grid Dynamics’s control and are difficult to predict. Factors that may cause such differences include\, but are not limited to\, potential exercises of the Public Warrants and other risks and uncertainties indicated in Grid Dynamics filings with the SEC. \n\n\n\nGrid Dynamics cautions that the foregoing list of factors is not exclusive. Grid Dynamics cautions readers not to place undue reliance upon any forward-looking statements\, which speak only as of the date made. Grid Dynamics does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events\, conditions or circumstances on which any such statement is based. Further information about factors that could materially affect Grid Dynamics\, including its results of operations and financial condition\, is set forth under the “Risk Factors” section of the Company’s quarterly report on Form 10-Q filed May 6\, 2021 and in other periodic filings Grid Dynamics makes with the SEC. \n\n\n\n\n\n\n\nContacts\n\n\n\nGrid Dynamics Investor Relations:investorrelations@griddynamics.com
URL:https://commonstockwarrants.com/event/grid-dynamics-announces-redemption-of-public-warrants-nasdaq-gdyn-gdynw-begin/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/07/GDYN_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Denver:20210730T170000
DTEND;TZID=America/Denver:20210730T170000
DTSTAMP:20260415T182625
CREATED:20210730T124616Z
LAST-MODIFIED:20210730T124748Z
UID:691554-1627664400-1627664400@commonstockwarrants.com
SUMMARY:Cerevel Therapeutics Announces Redemption of Public Warrants (NASDAQ: CERE\, CEREW)- BEGIN
DESCRIPTION:Cerevel Therapeutics (Nasdaq: CERE; CEREW) (the “Company”)\, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases\, today announced that on August 30\, 2021 at 5:00 p.m. ET\, it will redeem all of its outstanding public warrants to purchase shares of the Company’s common stock that were issued under the Warrant Agreement\, dated as of June 9\, 2020\, by and between the Company (f/k/a ARYA Sciences Acquisition Corp II) and Continental Stock Transfer & Trust Company (“Continental”)\, as warrant agent. \n\n\n\nEach such public warrant may be exercised by the holder thereof to purchase one share of the Company’s common stock at the exercise price of $11.50 per public warrant. Any such public warrants that remain unexercised following 5:00 p.m. ET on August 30\, 2021 will be void and no longer exercisable\, and the holders of those public warrants will be entitled to receive only the redemption price of $0.01 per warrant. As a result of the redemption\, the public warrants will cease to be traded on Nasdaq following the close of trading on August 30\, 2021. \n\n\n\nBeneficial holders seeking to exercise public warrants should contact their brokerage firm as soon as possible to process the warrant exercise in advance of the redemption date. Brokers may have an earlier deadline for beneficial holders to exercise their public warrants than the deadline set forth above. \n\n\n\nUnder the terms of the Warrant Agreement\, the Company is entitled to redeem all of such outstanding public warrants if the last sale price of the Company’s common stock reported is at least $18.00 per share on each of twenty trading days within a thirty trading day period. This share price performance requirement was satisfied as of July 27\, 2021. Warrants to purchase common stock that were issued under the Warrant Agreement in a private placement and still held by initial holders thereof or their permitted transferees are not subject to this redemption. \n\n\n\nContinental\, in its capacity as warrant agent\, has delivered a notice of redemption to each of the registered holders of such outstanding public warrants on behalf of the Company.  The shares of common stock underlying such public warrants have been registered by the Company under the Securities Act of 1933\, as amended\, and are covered by a registration statement filed on Form S-1 with\, and declared effective by\, the Securities and Exchange Commission (File No. 333-250964).  \n\n\n\nQuestions concerning redemption and exercise of such public warrants can be directed to Georgeson\, 1290 Avenue of the Americas\, 9th Floor\, New York\, NY 10104\, telephone number (888) 663-7851. \n\n\n\nNone of the Company\, its board of directors or employees have made or are making any representation or recommendation to any warrant holder as to whether to exercise or refrain from exercising any warrants. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the Company’s securities and shall not constitute an offer\, solicitation or sale in any jurisdiction in which such offering\, solicitation or sale would be unlawful. \n\n\n\nAbout Cerevel Therapeutics \n\n\n\nCerevel Therapeutics is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling diseases with a targeted approach to neuroscience that combines expertise in neurocircuitry with a focus on receptor selectivity. Cerevel Therapeutics has a diversified pipeline comprising five clinical-stage investigational therapies and several pre-clinical compounds with the potential to treat a range of neuroscience diseases\, including Parkinson’s\, epilepsy\, schizophrenia\, and substance use disorder. Headquartered in Cambridge\, Mass.\, Cerevel Therapeutics is advancing its current research and development programs while exploring new modalities through internal research efforts\, external collaborations\, or potential acquisitions. For more information\, visit www.cerevel.com. \n\n\n\nForward-Looking Statements \n\n\n\nThis press release contains forward-looking statements that are based on management’s beliefs and assumptions and on information currently available to management. In some cases\, you can identify forward-looking statements by the following words: “may\,” “will\,” “could\,” “would\,” “should\,” “expect\,” “intend\,” “plan\,” “anticipate\,” “believe\,” “estimate\,” “predict\,” “project\,” “potential\,” “continue\,” “ongoing” or the negative of these terms or other comparable terminology\, although not all forward-looking statements contain these words. These statements involve risks\, uncertainties and other factors that may cause actual results\, levels of activity\, performance\, or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement contained in this press release\, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future\, about which we cannot be certain. Forward-looking statements in this press release include\, but are not limited to\, express or implied statements regarding the terms of the redemption and the amount of redemption requests made by holders of public warrants. We cannot assure you that the forward-looking statements in this press release will prove to be accurate. Furthermore\, if the forward-looking statements prove to be inaccurate\, the inaccuracy may be material. Actual performance and results may differ materially from those projected or suggested in the forward-looking statements due to various risks and uncertainties\, including\, among others: clinical trial results may not be favorable; uncertainties inherent in the product development process (including with respect to the timing of results and whether such results will be predictive of future results); the impact of COVID-19 on the timing\, progress and results of ongoing or planned clinical trials; other impacts of COVID-19\, including operational disruptions or delays or to our ability to raise additional capital; whether and when\, if at all\, our product candidates will receive approval from the FDA or other regulatory authorities\, and for which\, if any\, indications; competition from other biotechnology companies; uncertainties regarding intellectual property protection; and other risks identified in our SEC filings\, including those under the heading “Risk Factors” in our Quarterly Report on Form 10-Q filed with the SEC on May 17\, 2021 and our subsequent SEC filings. In light of the significant uncertainties in these forward-looking statements\, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame\, or at all. The forward-looking statements in this press release represent our views as of the date of this press release. We anticipate that subsequent events and developments will cause our views to change. However\, while we may elect to update these forward-looking statements at some point in the future\, we have no current intention of doing so except to the extent required by applicable law. You should\, therefore\, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this press release. \n\n\n\nMedia Contact:Kate ContrerasReal Chemistrykcontreras@realchemistry.com \n\n\n\nInvestor Contact:Matthew CalistriCerevel Therapeuticsmatthew.calistri@cerevel.com
URL:https://commonstockwarrants.com/event/cerevel-therapeutics-announces-redemption-of-public-warrants-nasdaq-cere-cerew-begin/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/07/CEREVEL_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210809T170000
DTEND;TZID=America/New_York:20210809T170000
DTSTAMP:20260415T182625
CREATED:20210712T030942Z
LAST-MODIFIED:20210712T031008Z
UID:691197-1628528400-1628528400@commonstockwarrants.com
SUMMARY:Hims & Hers Completes Redemption of All Outstanding Warrants (NYSE: HIMS\, HIMS.WS) - END
DESCRIPTION:Hims & Hers Health\, Inc. (“Hims & Hers” or the “Company\,” NYSE: HIMS)\, the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers\, today announced that it will redeem all of its outstanding warrants (the “Warrants”) to purchase shares of the Company’s Class A common stock\, par value $0.0001 per share (the “Common Stock”)\, that were issued under the Warrant Agreement\, dated July 22\, 2019 (the “Warrant Agreement”)\, by and between the Company and Continental Stock Transfer & Trust Company\, as warrant agent (the “Warrant Agent”)\, that remain outstanding at 5:00 p.m. New York City time on August 9\, 2021 (the “Redemption Date”) for a redemption price of $0.10 per Warrant. The Warrants consist of (i) the units sold in the Company’s initial public offering (the “Public Warrants”) and (ii) warrants to purchase shares of Common Stock previously held by Oaktree Acquisition Holdings\, L.P.\, the Company’s sponsor\, that were cancelled and issued or issuable to former stockholders of Hims\, Inc. in connection with the Company’s business combination that closed in January 2021. As previously announced\, in February 2021 all of the outstanding Private Placement Warrants (as defined in the Warrant Agreement) were net exercised. \n\n\n\nUnder the terms of the Warrant Agreement\, the Company is entitled to redeem all of the outstanding Warrants at a redemption price of $0.10 per Warrant if the last sales price (the “Reference Value”) of the Common Stock is at least $10.00 per share on the trading day prior to the date on which a notice of redemption is given. At the direction of the Company\, the Warrant Agent has delivered a notice of redemption to each of the registered holders of the outstanding Warrants. In addition\, the New York Stock Exchange intends to halt trading on the Public Warrants after close of market on August 6. 2021. The redemption will not affect trading of the Company’s Common Stock. \n\n\n\nThe Warrants may be exercised by the holders thereof until 5:00 p.m. New York City time on the Redemption Date to purchase fully paid and non-assessable shares of Common Stock underlying such Warrants. Payment upon exercise of the Warrants may be made either (i) in cash\, at an exercise price of $11.50 per share of Common Stock or (ii) on a “cashless basis” in which the exercising holder will receive 0.267 shares per Warrant\, which is the number of shares of Common Stock determined in accordance with the terms of the Warrant Agreement and based on the Redemption Date\, August 9\, 2021\, and the average last sale price of the Common Stock during the ten (10) trading days ending on the third trading day prior to the date on which the notice of redemption is sent to holders of Warrants\, which was $10.78 (the “Fair Market Value”). If any holder of Warrants would\, after taking into account all of such holder’s Warrants exercised at one time\, be entitled to receive a fractional interest in a share of Common Stock\, the number of shares such holder will be entitled to receive will be rounded down to the nearest whole number of shares. \n\n\n\nAny Warrants that remain unexercised at 5:00 p.m. New York City time on the Redemption Date will be void and no longer exercisable\, and the holders of those Warrants will be entitled to receive only the redemption price of $0.10 per Warrant. \n\n\n\nNone of the Company\, its board of directors or employees has made or is making any representation or recommendation to any holder of the Warrants as to whether to exercise or refrain from exercising any Warrants. \n\n\n\nA registration statement on Form S-1 under the Securities Act of 1933\, as amended\, has been filed with\, and declared effective by\, the Securities and Exchange Commission (Registration No. 333-252814) covering the Common Stock issuable upon exercise of the Warrants. The SEC maintains an Internet website that contains a copy of this prospectus. The address of that site is www.sec.gov. Alternatively\, you can obtain a copy of the prospectus from the Company’s investor relations website at https://investors.forhims.com/. \n\n\n\nQuestions concerning redemption and exercise of the Warrants can be directed to our Warrant Agent\, Continental Stock Transfer & Trust Company\, at 1 State Street 30th Floor\, New York\, NY 10004-1561\, by telephone at (212) 509-4000 or by email at reorg@continentalstock.com \n\n\n\nNo Offer or Solicitation \n\n\n\nThis press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any offer of any of the Company’s securities in any jurisdiction in which such offer\, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. \n\n\n\nForward Looking Statements \n\n\n\nThis press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933\, as amended and Section 21E of the Securities Exchange Act of 1934\, as amended. These forward-looking statements can be identified by the use of forward-looking terminology\, including the word “will\,” or its negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations. Such statements include\, but are not limited to\, expectations regarding the redemption of the Warrants. These statements are based on management’s current expectations\, but actual results may differ materially due to various factors. By their nature\, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. \n\n\n\nThe forward-looking statements contained in this press release are based on our current expectations and beliefs concerning future developments and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks\, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include\, but are not limited to\, risks related to the redemption of the Warrants\, as well as those factors described in the “Risk Factors” section and other sections of our most recent Annual Report on Form 10-K\, most recent Quarterly Report on Form 10-Q and other current and periodic reports we file from time to time. \n\n\n\nShould one or more of these risks or uncertainties materialize\, or should any of our assumptions prove incorrect\, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements\, whether as a result of new information\, future events or otherwise\, except as may be required under applicable securities laws. \n\n\n\nAbout Hims & Hers \n\n\n\nHims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals\, enabling them to access high-quality medical care for numerous conditions related to primary care\, mental health\, sexual health\, dermatology\, and more. Launched in November 2017\, the company also offers thoughtfully created and curated health and wellness products. With products and services available across all 50 states and Washington\, D.C.\, Hims & Hers is able to provide access to quality\, convenient and affordable care for all Americans. Hims & Hers was founded by CEO Andrew Dudum\, Hilary Coles\, Jack Abraham and Joe Spector at venture studio Atomic in San Francisco\, California. For more information about Hims & Hers\, please visit forhims.com and forhers.com. \n\n\n\n\n\n\n\nContacts\n\n\n\nLinda O’Connorpress@forhims.com
URL:https://commonstockwarrants.com/event/hims-hers-completes-redemption-of-all-outstanding-warrants-nyse-hims-hims-ws-end/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/07/HIMS_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210816T170000
DTEND;TZID=America/New_York:20210816T170000
DTSTAMP:20260415T182625
CREATED:20210716T150449Z
LAST-MODIFIED:20210716T150510Z
UID:691302-1629133200-1629133200@commonstockwarrants.com
SUMMARY:Skillz Completes Redemption of Public Warrants (NYSE: SKLZ\, SKLZ.WS) -END
DESCRIPTION:SAN FRANCISCO–(BUSINESS WIRE)–Skillz Inc. (NYSE: SKLZ) (“Skillz”)\, the leading mobile games platform bringing fair and fun competition to players worldwide\, today announced that it will redeem all of its outstanding public warrants to purchase shares of Skillz’s Class A common stock that were issued under the Warrant Agreement\, dated as of March 5\, 2020 (the “Warrant Agreement”)\, by and among Flying Eagle Acquisition Corp. and Continental Stock Transfer & Trust Company\, as warrant agent and transfer agent (“Continental”)\, and that remain outstanding following 5pm New York City time on August 16\, 2021 for a redemption price of $0.01 per warrant. Warrants that were issued under the Warrant Agreement in a private placement and still held by Eagle Equity Partners II\, LLC\, a Delaware limited liability company\, or its permitted transferees are not subject to this notice of redemption. \n\n\n\nUnder the terms of the Warrant Agreement\, Skillz is entitled to redeem all of such outstanding public warrants if the reported closing price of Skillz’s Class A common stock is at least $18.00 per share on each of 20 trading days within a 30 trading day period. This share price performance requirement was satisfied as of July 13\, 2021. \n\n\n\nContinental\, in its capacity as warrant agent\, has delivered a notice of redemption to each of the registered holders of such outstanding public warrants on behalf of Skillz. \n\n\n\nAll such public warrants may be exercised by the holders thereof until 5pm New York City time on August 16\, 2021\, to purchase fully paid and non-assessable shares of Common Stock underlying such warrants\, at the exercise price of $11.50 per share. \n\n\n\nAny such public warrants that remain unexercised following 5pm New York City time on August 16\, 2021\, will be void and no longer exercisable\, and the holders of those public warrants will be entitled to receive only the redemption price of $0.01 per warrant. \n\n\n\nThe shares of Class A common stock underlying such public warrants have been registered by Skillz under the Securities Act of 1933\, as amended\, and are covered by a registration statement filed on Form S-1 with\, and declared effective by\, the Securities and Exchange Commission (Registration No. 333-252868). \n\n\n\nQuestions concerning redemption and exercise of such public warrants can be directed to: Continental Stock Transfer & Trust Company\, 1 State Street\, 30th Floor\, New York\, NY 10004\, telephone number 212-509-4000. \n\n\n\nFor a copy of the notice of redemption sent to the holders of such public warrants\, please visit the Skillz investor relations website at https://investors.skillz.com/. \n\n\n\nThis press release shall not constitute an offer to sell or the solicitation of an offer to buy any Skillz securities and shall not constitute an offer\, solicitation\, or sale in any jurisdiction in which such offering\, solicitation\, or sale would be unlawful. \n\n\n\nAbout Skillz Inc. \n\n\n\nSkillz is the leading mobile games platform that connects players in fair\, fun\, and meaningful competition. The Skillz platform helps developers build multi-million dollar franchises by enabling social competition in their games. Leveraging its patented technology\, Skillz hosts billions of casual esports tournaments for millions of mobile players worldwide\, and distributes millions in prizes each month. Skillz has earned recognition as one of Fast Company’s Most Innovative Companies\, CNBC’s Disruptor 50\, Forbes’ Next Billion-Dollar Startups\, and the #1 fastest-growing company in America on the Inc. 5000. www.skillz.com \n\n\n\nForward Looking Statements \n\n\n\nThis press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. The Company’s actual results may differ from its expectations\, estimates\, and projections and\, consequently\, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect\,” “estimate\,” “project\,” “budget\,” “forecast\,” “anticipate\,” “intend\,” “plan\,” “may\,” “will\,” “could\,” “should\,” “believes\,” “predicts\,” “potential\,” “continue\,” and similar expressions (or the negative versions of such words or expressions) are intended to identify such forward-looking statements. \n\n\n\nThese forward-looking statements involve significant risks and uncertainties that could cause the Company’s actual results to differ materially from those discussed in the forward-looking statements. Most of these factors are outside of the Company’s control and are difficult to predict. Factors that may cause such differences include\, but are not limited to\, the ability of Skillz to:realize the benefits expected from the business combination; effectively compete in the global entertainment and gaming industries; attract and retain successful relationships with the third party developers that develop and update all of the games hosted on Skillz’s platform; comply with laws and regulations applicable to its business; and as well as other risks and uncertainties indicated from time to time in the Company’s SEC filings\, including those under “Risk Factors” therein\, which are available on the SEC’s website at www.sec.gov. Additional information will be made available in other filings that the Company makes from time to time with the SEC. In addition\, any forward-looking statements contained in this press release are based on assumptions that the Company believes to be reasonable as of this date. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events\, except as required by law.
URL:https://commonstockwarrants.com/event/skillz-completes-redemption-of-public-warrants-nyse-sklz-sklz-ws-end/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/jpeg:https://commonstockwarrants.com/wp-content/uploads/2021/07/SKLZ_Logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Denver:20210820T080000
DTEND;TZID=America/Denver:20210820T170000
DTSTAMP:20260415T182625
CREATED:20210820T132553Z
LAST-MODIFIED:20210820T132603Z
UID:691810-1629446400-1629478800@commonstockwarrants.com
SUMMARY:Stem Issues Notice of Redemption for Public Warrants (NYSE: STEM\, STEM.WS) - BEGIN
DESCRIPTION:SAN FRANCISCO–(BUSINESS WIRE)–Stem\, Inc. (“Stem” or “the Company”) today issued the following notice of redemption for all of Company’s outstanding public warrants. The Company expects that the public warrants will cease trading on Friday\, September 17\, the last trading day before the Redemption Date (as defined below)\, and will be delisted from the New York Stock Exchange on the Redemption Date. \n\n\n\nAugust 20\, 2021 \n\n\n\nNOTICE OF REDEMPTION OF PUBLIC WARRANTS (CUSIP 85859N110) \n\n\n\nDear Warrant Holder\, \n\n\n\nStem\, Inc. (the “Company”) hereby gives notice that it is redeeming\, at 5:00 p.m. New York City time on September 20\, 2021 (the “Redemption Date”)\, all of the Company’s outstanding Public Warrants (as defined in the Warrant Agreement (defined below)) (the “Warrants”) to purchase shares of the Company’s common stock\, $0.0001 par value per share (the “Common Stock”) for a redemption price of $0.01 per Warrant (the “Redemption Price”)\, that were issued under the Warrant Agreement dated as of August 20\, 2020 (the “Warrant Agreement”)\, by and between the Company’s predecessor company\, Star Peak Energy Transition Corp. (“STPK”)\, and Continental Stock Transfer & Trust Company\, as warrant agent (the “Warrant Agent”)\, as part of the units sold in STPK’s initial public offering. Each Warrant entitles the holder thereof to purchase one share of Common Stock for a purchase price of $11.50 per whole share\, subject to adjustment. Any Warrants that remain unexercised at 5:00 p.m. New York City time on the Redemption Date will be void and no longer exercisable and their holders will have no rights with respect to those Warrants\, except to receive the Redemption Price or as otherwise described in this notice for holders who hold their Warrants in “street name.” \n\n\n\nThe Warrants are listed on the New York Stock Exchange (the “NYSE”) under the symbol “STEM.WS” and the Common Stock is listed on the NYSE under the symbol “STEM.” On August 19\, 2021\, the last reported sale price of the Warrants was $9.77 and the last reported sale price of the Common Stock was $21.34 per share. We expect that the NYSE will suspend trading in the Warrants prior to the opening of trading on the Redemption Date\, and that the last day of trading will be the immediately preceding trading day\, which is expected to be Friday\, September 17\, 2021. \n\n\n\nTERMS OF REDEMPTION; CESSATION OF RIGHTS \n\n\n\nThe rights of the Warrant holders to exercise their Warrants will terminate immediately prior to 5:00 p.m. New York City time on the Redemption Date. At 5:00 p.m. New York City time on the Redemption Date and thereafter\, the Warrants will no longer be exercisable and the holders of unexercised Warrants will have no rights with respect to those Warrants\, except to receive the Redemption Price or as otherwise described in this notice for holders who hold their Warrants in “street name.” We encourage you to consult with your broker\, financial advisor and/or tax advisor to consider whether or not to exercise your Warrants. Note that the act of exercising is VOLUNTARY\, meaning holders must instruct their broker to submit the Warrants for exercise. \n\n\n\nThe Company is exercising this right to redeem the Warrants pursuant to Section 6 of the Warrant Agreement. Pursuant to Section 6.1 of the Warrant Agreement\, the Company has the right to redeem all of the outstanding Warrants if the last sales price of the Common Stock reported has been at least $18.00 per share on each of 20 trading days within the 30 trading-day period ending on the third trading day prior to the date on which a notice of redemption is given. The last sales price of the Common Stock has been at least $18.00 per share on each of 20 trading days within the 30 trading-day period ending on August 17\, 2021 (which is the third trading day prior to the date of this redemption notice). \n\n\n\nEXERCISE PROCEDURE \n\n\n\nWarrant holders have until 5:00 p.m. New York City time on the Redemption Date to exercise their Warrants to purchase shares of Common Stock. Warrants may only be exercised for cash. Each Warrant entitles the holder thereof to purchase one share of Common Stock at a cash price of $11.50 per whole share (the “Exercise Price”). \n\n\n\nPayment of the exercise funds may be made by wire transfer of immediately available funds. Wire instructions will be provided to the Depository Trust Company and will otherwise be provided upon request. \n\n\n\nThose who hold their Warrants in “street name” should immediately contact their broker to determine their broker’s procedure for exercising their Warrants since the process to exercise is VOLUNTARY. \n\n\n\nPersons who are holders of record of their Warrants may exercise their Warrants by sending: \n\n\n\nThe Warrant Certificate;A fully and properly completed “Election to Purchase” (a form of which is attached hereto as Annex A)\, duly executed and indicating\, among of things\, the number of Warrants being exercised; andThe exercise funds via wire transfer\,\n\n\n\nto: \n\n\n\nContinental Stock Transfer & Trust Company1 State Street\, 30th FloorNew York\, NY 10004Attention: Compliance DepartmentTelephone: (212) 509-4000 \n\n\n\nThe method of delivery of the Warrants is at the option and risk of the holder\, but if mail is used\, registered mail properly insured is suggested. \n\n\n\nThe Warrant Certificate\, the fully and properly completed Election to Purchase and the exercise funds must be received by Continental Stock Transfer & Trust Company prior to 5:00 p.m. New York City time on the Redemption Date. Subject to the following paragraph\, any failure to deliver a fully and properly completed Election to Purchase together with the related Warrant Certificate and exercise funds before such time will result in such holder’s Warrants being redeemed at the Redemption Price of $0.01 per Warrant and not exercised. \n\n\n\nFor holders of Warrants who hold their Warrants in “street name\,” provided that the Exercise Price for the Warrants being exercised and a Notice of Guaranteed Delivery and the exercise funds are received by the Warrant Agent prior to 5:00 p.m. New York City time on the Redemption Date\, broker-dealers shall have two business days from the Redemption Date\, or 5:00 p.m. New York City time on September 22\, 2021\, to deliver the Warrants to the Warrant Agent. Any such Warrant received without an Election to Purchase and a Notice of Guaranteed Delivery having been duly executed and fully and properly completed or the exercise funds being submitted will be deemed to have been delivered for redemption at the Redemption Price of $0.01 per Warrant\, and not for exercise. \n\n\n\nPROSPECTUS \n\n\n\nA prospectus covering the shares of Common Stock issuable upon the exercise of the Warrants (and the supplements thereto) is included in a registration statement filed with\, and declared effective by\, the Securities and Exchange Commission (Registration No. 333-256501) (the “SEC”). The SEC also maintains an Internet website that contains a copy of this prospectus. The address of this site is www.sec.gov. Alternatively\, to obtain a copy of the prospectus (and the supplements thereto)\, please visit our investor relations website (investors.stem.com). \n\n\n\nREDEMPTION PROCEDURE \n\n\n\nPayment of the Redemption Price will be made by the Company upon presentation and surrender of a Warrant for payment after 5:00 p.m. New York City time on the Redemption Date. Those who hold their shares in “street name” should contact their broker to determine their broker’s procedure for redeeming their Warrants. \n\n\n\n********************************* \n\n\n\nAny questions you may have about redemption and exercising your Warrants may be directed to the Warrant Agent at its address and telephone number set forth above\, or at compliance@continentalstock.com. \n\n\n\nSincerely\,STEM\, INC. \n\n\n\n/s/ William Bush \n\n\n\n________________________________ \n\n\n\nName: William BushTitle: Chief Financial Officer \n\n\n\nANNEX A \n\n\n\nSTEM\, INC. \n\n\n\nElection to Purchase \n\n\n\n(To Be Executed Upon Exercise of Warrant) \n\n\n\nThe undersigned hereby irrevocably elects to exercise the right\, represented by this Warrant Certificate\, to receive ____________ shares of Common Stock and herewith tenders payment for such shares of Common Stock\, $0.0001 par value per share (the “Common Stock”) to the order of Stem\, Inc. (the “Company”) in the amount of $____________ in accordance with the terms hereof. The undersigned requests that a certificate for such shares of Common Stock be registered in the name of ____________\, whose address is _________________ and that such shares of Common Stock be delivered to ____________ whose address is _________________. \n\n\n\n____________________________________ \n\n\n\n(Date) \n\n\n\n____________________________________ \n\n\n\n(Signature) \n\n\n\n____________________________________ \n\n\n\n____________________________________ \n\n\n\n____________________________________ \n\n\n\n(Address) \n\n\n\n____________________________________ \n\n\n\n(Tax Identification Number) \n\n\n\nSignature Guaranteed: \n\n\n\n__________________________________________________ \n\n\n\nTHE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS\, STOCKBROKERS\, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM\, PURSUANT TO SEC RULE 17Ad-15 (OR ANY SUCCESSOR RULE)) UNDER THE SECURITIES EXCHANGE ACT OF 1934\, AS AMENDED. \n\n\n\nCautionary Statement regarding Forward-Looking Statements \n\n\n\nThis press release contains “forward-looking statements” within the meaning of the federal securities laws. Forward-looking statements address matters that are\, to varying degrees\, uncertain\, such as the expected redemption of the public warrants\, and the delisting of the public warrants from the New York Stock Exchange. These statements are subject to risks and uncertainties\, including\, but not limited to\, the possibility that the redemption may not occur\, and other risks and uncertainties set forth in the section entitled “Risk Factors” in the registration statement on Form S-1 filed with the SEC on July 19\, 2021\, and our most recent Forms 10-K\, 10-Q and 8-K filed with or furnished to the SEC. If one or more of these or other risks or uncertainties materialize (or the consequences of such a development changes)\, or should underlying assumptions prove incorrect\, actual outcomes may vary materially from those reflected in our forward-looking statements. The forward-looking statements speak only as of the date of this press release\, and Stem disclaims any intention or obligation to update publicly or revise such statements\, whether as a result of new information\, future events or otherwise. \n\n\n\n\n\n\n\nContacts\n\n\n\nStem Investor ContactsTed Durbin\, StemMarc Silverberg\, ICRIR@stem.comStem Media ContactCory Ziskind\, ICRstemPR@icrinc.com
URL:https://commonstockwarrants.com/event/stem-issues-notice-of-redemption-for-public-warrants-nyse-stem-stem-ws-begin/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/jpeg:https://commonstockwarrants.com/wp-content/uploads/2021/08/STEM_logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210823T170000
DTEND;TZID=America/New_York:20210823T170000
DTSTAMP:20260415T182625
CREATED:20210722T135246Z
LAST-MODIFIED:20210722T135250Z
UID:691407-1629738000-1629738000@commonstockwarrants.com
SUMMARY:Clover Health Investments\, Corp. Completing Redemption of All Outstanding Warrants (NASDAQ: CLOV\, CLOVW) -END
DESCRIPTION:Clover Health Investments\, Corp. (Nasdaq: CLOV)\, (“Clover Health” or “the Company”)\, an innovative technology company committed to improving health equity for America’s underserved seniors\, today announced that the Company will redeem all of its outstanding warrants (the “Public Warrants”) to purchase shares of the Company’s common stock\, par value $0.0001 per share (the “Common Stock”)\, that were issued under the Warrant Agreement\, dated April 21\, 2020\, by and between the Company and Continental Stock Transfer & Trust Company (the “Warrant Agent”)\, as warrant agent (the “Warrant Agreement”)\, as part of the units sold in the Company’s initial public offering (the “IPO”) and that remain outstanding at 5:00 p.m. New York City time on August 23\, 2021 (the “Redemption Date”) for a redemption price of $0.10 per Public Warrant. In addition\, the Company will redeem all of its outstanding warrants to purchase Common Stock that were issued under the Warrant Agreement in a private placement simultaneously with the IPO (the “Private Warrants” and\, together with the Public Warrants\, the “Warrants”) on the same terms as the outstanding Public Warrants. \n\n\n\nUnder the terms of the Warrant Agreement\, the Company is entitled to redeem all of the outstanding Public Warrants at a redemption price of $0.10 per Public Warrant if (i) the last reported sales price (the “Reference Value”) of the Common Stock is at least $10.00 per share for any twenty trading days within the thirty-day trading period ending on the third trading day prior to the date on which a notice of redemption is given and (ii) if the Reference Value is less than $18.00 per share\, the Private Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants. At the direction of the Company\, the Warrant Agent has delivered a notice of redemption to each of the registered holders of the outstanding Warrants. \n\n\n\nThe Warrants may be exercised by the holders thereof until 5:00 p.m. New York City time on the Redemption Date to purchase fully paid and non-assessable shares of Common Stock underlying such Warrants. As the Reference Value is less than $18.00 per share\, payment upon exercise of the Warrants may be made either (i) in cash\, at an exercise price of $11.50 per share of Common Stock or (ii) on a “cashless basis” in which the exercising holder will receive a number of shares of Common Stock to be determined in accordance with the terms of the Warrant Agreement and based on the Redemption Date and the volume weighted average price (the “Fair Market Value”) of the Common Stock during the 10 trading days immediately following the date on which the notice of redemption is sent to holders of Warrants. The Company will inform holders of the Fair Market Value no later than one business day after such 10-trading day period ends. In no event will the number of shares of Common Stock issued in connection with an exercise on a cashless basis exceed 0.361 shares of Common Stock per Warrant. If any holder of Warrants would\, after taking into account all of such holder’s Warrants exercised at one time\, be entitled to receive a fractional interest in a share of Common Stock\, the number of shares the holder will be entitled to receive will be rounded down to the nearest whole number of shares. \n\n\n\nAny Warrants that remain unexercised at 5:00 p.m. New York City time on the Redemption Date will be void and no longer exercisable\, and the holders of those Warrants will be entitled to receive only the redemption price of $0.10 per Warrant. \n\n\n\n\n\n\n\nNone of the Company\, its board of directors or employees has made or is making any representation or recommendation to any holder of the Warrants as to whether to exercise or refrain from exercising any Warrants. \n\n\n\nThe shares of Common Stock underlying the Warrants have been registered by the Company under the Securities Act of 1933\, as amended\, and are covered by a registration statement filed on Form S-1 with\, and declared effective by\, the Securities and Exchange Commission (Registration No. 333-252073). The SEC maintains an Internet website that contains a copy of this prospectus. The address of that site is www.sec.gov. Alternatively\, you can obtain a copy of the prospectus from the Company’s investor relations website at https://investors.cloverhealth.com. \n\n\n\nQuestions concerning redemption and exercise of the Warrants can be directed to our information agent\, MacKenzie Partners\, Inc.\, at 1407 Broadway\, New York\, NY 10018\, telephone number: (800) 322-2885. \n\n\n\nNo Offer or Solicitation \n\n\n\nThis press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any offer of any of the Company’s securities in any jurisdiction in which such offer\, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. \n\n\n\nForward Looking Statements \n\n\n\nThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933\, as amended\, and Section 21E of the Securities Exchange Act of 1934\, as amended. Forward-looking statements include statements regarding future events. In some cases\, you can identify forward looking statements because they contain words such as “may\,” “will\,” “should\,” “expects\,” “plans\,” “anticipates\,” “going to\,” “can\,” “could\,” “should\,” “would\,” “intends\,” “target\,” “projects\,” “contemplates\,” “believes\,” “estimates\,” “predicts\,” “potential\,” “outlook\,” “forecast\,” “objective\,” “plan\,” “seek\,” “grow\,” “target\,” “if\,” “continue” or the negative of these words or other similar terms or expressions that concern Clover Health’s expectations\, strategy\, priorities\, plans or intentions. These statements are subject to known and unknown risks\, uncertainties and other factors that may cause our actual results to differ materially from results expressed or implied in this press release\, including but not limited to the risks and uncertainties contained in the Risk Factors section of our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31\, 2021. Clover Health assumes no obligation\, and does not intend\, to update these forward-looking statements as a result of future events or developments. \n\n\n\nAbout Clover Health \n\n\n\nClover Health (Nasdaq: CLOV) is a next-generation risk-bearing organization aiming to achieve health equity for all Americans. While our mission is to improve every life\, we particularly focus on seniors who have historically lacked access to affordable high quality healthcare.
URL:https://commonstockwarrants.com/event/clover-health-investments-corp-completing-redemption-of-all-outstanding-warrants-nasdaq-clov-clovw-end/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/jpeg:https://commonstockwarrants.com/wp-content/uploads/2021/07/CLOV_logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210824T170000
DTEND;TZID=America/New_York:20210824T170000
DTSTAMP:20260415T182625
CREATED:20210723T133829Z
LAST-MODIFIED:20210823T063116Z
UID:691419-1629824400-1629824400@commonstockwarrants.com
SUMMARY:QuantumScape Finalizes Redemption of Public Warrants (NYSE: QS\, QS.WS) -END
DESCRIPTION:SAN JOSE\, Calif.–(BUSINESS WIRE)–QuantumScape Corporation (“QuantumScape\,” Class A Common Stock – NYSE: QS; Public Warrants – NYSE: QS.WS) today announced that it has elected to redeem\, at 5:00 p.m. Eastern Daylight Time on August 24\, 2021 (the “Redemption Date”)\, all of QuantumScape’s outstanding public warrants (“Public Warrants”) that were issued under the Warrant Agreement dated as of June 25\, 2020\, as amended on February 13\, 2021 (the “Warrant Agreement”)\, by and between Kensington Capital Acquisition Corp. (“Kensington”) and Continental Stock Transfer & Trust Company\, as warrant agent. The Public Warrants were originally issued in connection with Kensington’s initial public offering in June 2020 (the “IPO”)\, and subsequently assumed by QuantumScape in November 2020 in connection with the business combination by and among Kensington\, Kensington Merger Sub Corp.\, and QuantumScape Battery\, Inc. \n\n\n\nRegistered holders of Public Warrants will have until 5:00 p.m. Eastern Daylight Time on August 24\, 2021 to exercise their Public Warrants. Each Public Warrant entitles the holder thereof to purchase one share of Class A Common Stock at a price of $11.50 per Public Warrant (the “Exercise Price”). Each Public Warrant that remains outstanding as of the Redemption Date will be redeemed by QuantumScape for $0.01 (the “Redemption Price”). Any Public Warrants that remain unexercised at 5:00 p.m. Eastern Daylight Time on the Redemption Date will be delisted\, void and no longer exercisable\, and the holders will have no rights with respect to those Public Warrants\, except to receive the Redemption Price. If a holder of a Public Warrant does not wish for its Public Warrant to be redeemed\, it must exercise such Public Warrant before 5:00 p.m. Eastern Daylight Time on the Redemption Date. \n\n\n\nQuantumScape is exercising its right to redeem the Public Warrants pursuant to Section 6.1 of the Warrant Agreement that provides for the right to redeem all the outstanding Public Warrants if the last reported sales price of QuantumScape’s Class A Common Stock has been at least $18.00 per share on each of 20 trading days within the 30-trading-day period ending on the third business day prior to the date on which a notice of redemption is given. The reported sales price of QuantumScape’s Class A Common Stock has been at least $18.00 per share on each of 20 trading days within the 30-trading-day period ending on July 20\, 2021. \n\n\n\nAs a result of the redemption\, the Public Warrants will cease to be traded on the NYSE effective August 24\, 2021. \n\n\n\nAs of the time of this press release\, QuantumScape has 1\,544\,871 Public Warrants outstanding. If all such currently outstanding Public Warrants are exercised prior to the Redemption Date\, QuantumScape will issue an aggregate of 1\,544\,871 shares of Class A Common Stock and receive potential gross exercise proceeds of approximately $17.8 million. \n\n\n\nWarrants to purchase shares of Class A Common Stock that were issued under the Warrant Agreement in private placements simultaneously with the closing of the IPO\, as well as in connection with working capital loans made by Kensington Capital Sponsor LLC to Kensington (all such warrants\, the “Private Placement Warrants”) are still held by the initial holders or their permitted transferees are not subject to this redemption. However\, QuantumScape is considering the possible redemption of the Private Placement Warrants at a future date in accordance with the terms of the Warrant Agreement. \n\n\n\nNone of QuantumScape\, its board of directors or employees have made or are making any representation or recommendation to any warrant holder as to whether to exercise or refrain from exercising any warrants. \n\n\n\nThe shares of Class A Common Stock underlying the Public Warrants have been registered by QuantumScape under the Securities Act of 1933\, as amended\, and are covered by a registration statement filed on Form S-1 with\, and declared effective by\, the Securities and Exchange Commission (Registration No. 333-251433). \n\n\n\nBeneficial holders desiring to exercise their Public Warrants should contact the brokerage firm holding their Public Warrants immediately to process their exercise to avoid redemption. Brokers will likely have an earlier deadline for beneficial holders to exercise their Public Warrants than the deadline for registered holders set forth above. \n\n\n\nNo Offer or Solicitation \n\n\n\nThis press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any offer of any of QuantumScape’s securities in any jurisdiction in which such offer\, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. \n\n\n\nForward-Looking Statements \n\n\n\nThe information in this press release includes a “forward-looking statement” within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934\, as amended\, including statements regarding the treatment of the Public Warrant\, the number of shares of Class A Common Stock to be issued\, the proceeds to be received in connection with the exercise of Public Warrants prior to the Redemption Date and the Company’s intentions regarding the potential redemption of Private Placement Warrants. \n\n\n\nThese forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside QuantumScape’s control and are difficult to predict\, including\, but not limited to\, fewer than all holders of Public Warrants exercising their Public Warrants prior to the Redemption Date. The foregoing factor is not exhaustive. Readers are cautioned not to put undue reliance on forward-looking statements. Information about other factors that could materially affect QuantumScape is set forth under the “Risk Factors” section in the QuantumScape’s registration statement on Form S-1 filed with the Securities and Exchange Commission on May 17\, 2021\, and available on the SEC’s website at www.sec.gov. \n\n\n\nExcept as otherwise required by applicable law\, QuantumScape disclaims any duty to update any forward-looking statements\, all of which are expressly qualified by the statements in this section\, to reflect events or circumstances after the date of this press release. Should underlying assumptions prove incorrect\, actual results and projections could different materially from those expressed in any forward-looking statements. \n\n\n\nAbout QuantumScape \n\n\n\nQuantumScape is a leader in developing next-generation solid-state lithium-metal batteries for electric vehicles. The company is on a mission to revolutionize energy storage to enable a sustainable future. For more information\, please visit www.quantumscape.com. \n\n\n\n\n\n\n\nContacts\n\n\n\nFor InvestorsJohn Sager\, CFAHead of Investor Relationsir@quantumscape.com \n\n\n\nFor Mediamedia@quantumscape.com
URL:https://commonstockwarrants.com/event/quantumscape-announces-redemption-of-public-warrants-nyse-qs-qs-ws-end/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/07/QS_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210830T170000
DTEND;TZID=America/New_York:20210830T170000
DTSTAMP:20260415T182625
CREATED:20210728T150508Z
LAST-MODIFIED:20210728T150513Z
UID:691472-1630342800-1630342800@commonstockwarrants.com
SUMMARY:Grid Dynamics Completes Redemption of Public Warrants (Nasdaq: GDYN; GDYNW) -END
DESCRIPTION:Grid Dynamics Holdings\, Inc. (Nasdaq: GDYN; GDYNW) (“Grid Dynamics”)\, a leader in enterprise-level digital transformation\, today announced that holders of its 2\,773\,141 outstanding public warrants (the “Public Warrants”) to purchase shares of its common stock\, $0.0001 par value per share (the “Common Stock”) will have until 5:00 p.m.\, New York City time\, on August 30\, 2021 (the “Redemption Date”) to exercise their Public Warrants. The Public Warrants are exercisable for an aggregate of 2\,773\,141 shares of Common Stock at a price of $11.50 per share\, representing a total of approximately $31.9 million in potential proceeds to Grid Dynamics. \n\n\n\nPursuant to the terms of the agreements governing the rights of the holders of the Public Warrants\, Grid Dynamics is entitled to redeem all of the outstanding Public Warrants for a redemption price of $0.01 per Public Warrant (the “Redemption Price”) if the last sales price of the Common Stock is at least $18.00 per share on each of twenty (20) trading days within the thirty (30) trading-day period ending on the third trading day prior to the date on which a notice of redemption is given. This share price performance target has been met. Any Public Warrants that remain unexercised immediately after 5:00 p.m.\, New York City time\, on August 30\, 2021 will be void and no longer exercisable\, and the holders of those Public Warrants will be entitled to receive $0.01 per Public Warrant. \n\n\n\nHolders of Public Warrants in “street name” should immediately contact their broker to determine their broker’s procedure for exercising their Public Warrants since the process to exercise is voluntary. Brokers will likely have an earlier deadline for beneficial holders to exercise their Public Warrants than the deadline for registered holders set forth above. If a holder of a Public Warrant does not wish for its Public Warrant to be redeemed\, it must exercise such Public Warrant before 5:00 p.m. New York City time on the Redemption Date. \n\n\n\nThe Public Warrants were issued under the Warrant Agreement\, dated as of October 4\, 2018 (the “Warrant Agreement”)\, by and between Grid Dynamics’ predecessor company\, ChaSerg Technology Acquisition Corp.\, and Continental Stock Transfer & Trust Company\, as warrant agent (the “Warrant Agent”). \n\n\n\nAs a result of the redemption\, the Public Warrants will cease to be traded on the Nasdaq effective August 30\, 2021. \n\n\n\nGrid Dynamics also announced that none of its “Private Placement Warrants” or “Working Capital Warrants” remained outstanding. \n\n\n\nNone of Grid Dynamics\, its board of directors or employees has made or is making any representation or recommendation to any holder of the Public Warrants as to whether to exercise or refrain from exercising any Public Warrants. \n\n\n\nThe shares of Common Stock underlying the Public Warrants have been registered by Grid Dynamics under the Securities Act of 1933\, as amended\, and are covered by a registration statement filed with\, and declared effective by\, the Securities and Exchange Commission (Registration No. 333‑238202). \n\n\n\nQuestions concerning redemption and exercise of the Public Warrants can be directed to Continental Stock Transfer & Trust Company\, 1 State Street\, 30th Floor\, New York\, New York 10004\, Attention: Compliance Department\, telephone number (212) 509-4000. \n\n\n\nNo Offer or Solicitation \n\n\n\nThis press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any offer of any of Grid Dynamics’s securities in any jurisdiction in which such offer\, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. \n\n\n\nAbout Grid Dynamics Holdings\, Inc. \n\n\n\nGrid Dynamics (Nasdaq: GDYN) is a digital-native technology services provider that accelerates growth and bolsters competitive advantage for Fortune 1000 companies. Grid Dynamics provides digital transformation consulting and implementation services in omnichannel customer experience\, big data analytics\, search\, artificial intelligence\, cloud migration\, and application modernization. Grid Dynamics achieves high speed-to-market\, quality\, and efficiency by using technology accelerators\, an agile delivery culture\, and its pool of global engineering talent. Founded in 2006\, Grid Dynamics is headquartered in Silicon Valley with offices across the US\, UK\, Netherlands\, Mexico\, Central\, and Eastern Europe. To learn more about Grid Dynamics\, please visit www.griddynamics.com. \n\n\n\nForward Looking Statements \n\n\n\nThis communication contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that are not historical facts\, and involve risks and uncertainties that could cause actual results of Grid Dynamics to differ materially from those expected and projected. These forward-looking statements can be identified by the use of forward-looking terminology\, including the words “believes\,” “estimates\,” “anticipates\,” “expects\,” “intends\,” “plans\,” “may\,” “will\,” “potential\,” “projects\,” “predicts\,” “continue\,” or “should\,” or\, in each case\, their negative or other variations or comparable terminology. These forward-looking statements include\, without limitation\, statements regarding the redemption of the Public Warrants and the expected proceeds from the exercise of the Public Warrants. \n\n\n\nThese forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside Grid Dynamics’s control and are difficult to predict. Factors that may cause such differences include\, but are not limited to\, potential exercises of the Public Warrants and other risks and uncertainties indicated in Grid Dynamics filings with the SEC. \n\n\n\nGrid Dynamics cautions that the foregoing list of factors is not exclusive. Grid Dynamics cautions readers not to place undue reliance upon any forward-looking statements\, which speak only as of the date made. Grid Dynamics does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events\, conditions or circumstances on which any such statement is based. Further information about factors that could materially affect Grid Dynamics\, including its results of operations and financial condition\, is set forth under the “Risk Factors” section of the Company’s quarterly report on Form 10-Q filed May 6\, 2021 and in other periodic filings Grid Dynamics makes with the SEC. \n\n\n\n\n\n\n\nContacts\n\n\n\nGrid Dynamics Investor Relations:investorrelations@griddynamics.com
URL:https://commonstockwarrants.com/event/grid-dynamics-completes-redemption-of-public-warrants-nasdaq-gdyn-gdynw-end/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/07/GDYN_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210830T170000
DTEND;TZID=America/New_York:20210830T170000
DTSTAMP:20260415T182625
CREATED:20210730T124654Z
LAST-MODIFIED:20210730T142446Z
UID:691555-1630342800-1630342800@commonstockwarrants.com
SUMMARY:Cerevel Therapeutics Completes Redemption of Public Warrants (NASDAQ: CERE\, CEREW) -END
DESCRIPTION:Cerevel Therapeutics (Nasdaq: CERE; CEREW) (the “Company”)\, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases\, today announced that on August 30\, 2021 at 5:00 p.m. ET\, it will redeem all of its outstanding public warrants to purchase shares of the Company’s common stock that were issued under the Warrant Agreement\, dated as of June 9\, 2020\, by and between the Company (f/k/a ARYA Sciences Acquisition Corp II) and Continental Stock Transfer & Trust Company (“Continental”)\, as warrant agent. \n\n\n\nEach such public warrant may be exercised by the holder thereof to purchase one share of the Company’s common stock at the exercise price of $11.50 per public warrant. Any such public warrants that remain unexercised following 5:00 p.m. ET on August 30\, 2021 will be void and no longer exercisable\, and the holders of those public warrants will be entitled to receive only the redemption price of $0.01 per warrant. As a result of the redemption\, the public warrants will cease to be traded on Nasdaq following the close of trading on August 30\, 2021. \n\n\n\nBeneficial holders seeking to exercise public warrants should contact their brokerage firm as soon as possible to process the warrant exercise in advance of the redemption date. Brokers may have an earlier deadline for beneficial holders to exercise their public warrants than the deadline set forth above. \n\n\n\nUnder the terms of the Warrant Agreement\, the Company is entitled to redeem all of such outstanding public warrants if the last sale price of the Company’s common stock reported is at least $18.00 per share on each of twenty trading days within a thirty trading day period. This share price performance requirement was satisfied as of July 27\, 2021. Warrants to purchase common stock that were issued under the Warrant Agreement in a private placement and still held by initial holders thereof or their permitted transferees are not subject to this redemption. \n\n\n\nContinental\, in its capacity as warrant agent\, has delivered a notice of redemption to each of the registered holders of such outstanding public warrants on behalf of the Company.  The shares of common stock underlying such public warrants have been registered by the Company under the Securities Act of 1933\, as amended\, and are covered by a registration statement filed on Form S-1 with\, and declared effective by\, the Securities and Exchange Commission (File No. 333-250964).  \n\n\n\nQuestions concerning redemption and exercise of such public warrants can be directed to Georgeson\, 1290 Avenue of the Americas\, 9th Floor\, New York\, NY 10104\, telephone number (888) 663-7851. \n\n\n\nNone of the Company\, its board of directors or employees have made or are making any representation or recommendation to any warrant holder as to whether to exercise or refrain from exercising any warrants. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the Company’s securities and shall not constitute an offer\, solicitation or sale in any jurisdiction in which such offering\, solicitation or sale would be unlawful. \n\n\n\nAbout Cerevel Therapeutics \n\n\n\nCerevel Therapeutics is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling diseases with a targeted approach to neuroscience that combines expertise in neurocircuitry with a focus on receptor selectivity. Cerevel Therapeutics has a diversified pipeline comprising five clinical-stage investigational therapies and several pre-clinical compounds with the potential to treat a range of neuroscience diseases\, including Parkinson’s\, epilepsy\, schizophrenia\, and substance use disorder. Headquartered in Cambridge\, Mass.\, Cerevel Therapeutics is advancing its current research and development programs while exploring new modalities through internal research efforts\, external collaborations\, or potential acquisitions. For more information\, visit www.cerevel.com. \n\n\n\nForward-Looking Statements \n\n\n\nThis press release contains forward-looking statements that are based on management’s beliefs and assumptions and on information currently available to management. In some cases\, you can identify forward-looking statements by the following words: “may\,” “will\,” “could\,” “would\,” “should\,” “expect\,” “intend\,” “plan\,” “anticipate\,” “believe\,” “estimate\,” “predict\,” “project\,” “potential\,” “continue\,” “ongoing” or the negative of these terms or other comparable terminology\, although not all forward-looking statements contain these words. These statements involve risks\, uncertainties and other factors that may cause actual results\, levels of activity\, performance\, or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement contained in this press release\, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future\, about which we cannot be certain. Forward-looking statements in this press release include\, but are not limited to\, express or implied statements regarding the terms of the redemption and the amount of redemption requests made by holders of public warrants. We cannot assure you that the forward-looking statements in this press release will prove to be accurate. Furthermore\, if the forward-looking statements prove to be inaccurate\, the inaccuracy may be material. Actual performance and results may differ materially from those projected or suggested in the forward-looking statements due to various risks and uncertainties\, including\, among others: clinical trial results may not be favorable; uncertainties inherent in the product development process (including with respect to the timing of results and whether such results will be predictive of future results); the impact of COVID-19 on the timing\, progress and results of ongoing or planned clinical trials; other impacts of COVID-19\, including operational disruptions or delays or to our ability to raise additional capital; whether and when\, if at all\, our product candidates will receive approval from the FDA or other regulatory authorities\, and for which\, if any\, indications; competition from other biotechnology companies; uncertainties regarding intellectual property protection; and other risks identified in our SEC filings\, including those under the heading “Risk Factors” in our Quarterly Report on Form 10-Q filed with the SEC on May 17\, 2021 and our subsequent SEC filings. In light of the significant uncertainties in these forward-looking statements\, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame\, or at all. The forward-looking statements in this press release represent our views as of the date of this press release. We anticipate that subsequent events and developments will cause our views to change. However\, while we may elect to update these forward-looking statements at some point in the future\, we have no current intention of doing so except to the extent required by applicable law. You should\, therefore\, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this press release. \n\n\n\nMedia Contact:Kate ContrerasReal Chemistrykcontreras@realchemistry.com \n\n\n\nInvestor Contact:Matthew CalistriCerevel Therapeuticsmatthew.calistri@cerevel.com
URL:https://commonstockwarrants.com/event/cerevel-therapeutics-completes-redemption-of-public-warrants-nasdaq-cere-cerew-end/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/07/CEREVEL_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210908T080000
DTEND;TZID=America/New_York:20210908T170000
DTSTAMP:20260415T182625
CREATED:20210908T124345Z
LAST-MODIFIED:20210928T033008Z
UID:691840-1631088000-1631120400@commonstockwarrants.com
SUMMARY:Lucid Motors Announces Redemption of Outstanding Public Warrants (NSDQ: LCID\, LCIDW) - BEGIN
DESCRIPTION:NEWARK\, Calif.\, Sept. 8\, 2021 /PRNewswire/ — Lucid Group\, which is setting new standards with its advanced luxury EVs\, today announced that the Company will redeem all of its outstanding public warrants (the “Public Warrants”) to purchase shares of the Company’s Class A common stock that were issued under the Warrant Agreement dated July 29\, 2020 by and between the Company and Continental Stock Transfer & Trust Company as warrant agent (as assigned to and assumed by the Company and Equiniti Trust Company\, as transfer agent and warrant agent)\, as part of the units sold in the Company’s initial public offering (the “IPO”)\, for a redemption price of $0.01 per Public Warrant (the “Redemption Price”) that remain outstanding at 5:00 p.m. Eastern Time on October 8\, 2021 (the “Redemption Date”).   \n\n\n\n“We are pleased to announce the cashless redemption of our public warrants\,” said Peter Rawlinson\, CEO & CTO of Lucid Group. “This is an important milestone in streamlining our capital structure to eliminate outstanding public warrants at the same time as we see growing confidence in Lucid’s ground-breaking\, in-house developed electric vehicle technology\, which will soon arrive into the market in Lucid Air. Lucid has chosen in part to require cashless exercise of the Public Warrants to enable warrant holders\, including our retail investors\, to hold shares in Lucid without cash exercise. We also expect this action will minimize dilution from these public warrants.” \n\n\n\nThe Public Warrants are listed on Nasdaq under the symbol “LCIDW.” Each Public Warrant entitles the holder thereof to purchase one share of Class A common stock for a purchase price of $11.50 per share\, subject to adjustments (the “Exercise Price”). Under the terms of the Warrant Agreement\, Lucid is entitled to redeem all of the outstanding Public Warrants if the last sale price of the Class A common stock is at least $18.00 per share on each of twenty trading days within any thirty-day trading period ending on the third trading day prior to the date on which a notice of redemption is given. Lucid has directed the warrant agent to deliver a notice of redemption to each of the registered holders of the outstanding Public Warrants. Warrants to purchase Class A common stock that were issued under the Warrant Agreement in a private placement simultaneously with the IPO and still held by the initial holders thereof or their permitted transferees are not subject to this notice of redemption. \n\n\n\nThe Public Warrants will cease trading on Nasdaq at 5:00 pm Eastern Time on the Redemption Date. Any Public Warrants that remain unexercised at 5:00 pm Eastern Time on the Redemption Date will be delisted\, void and no longer exercisable\, and their holders will have no rights with respect to those Public Warrants except to receive the Redemption Price or as otherwise described in the redemption notice for holders who hold their Public Warrants in “street name.” \n\n\n\nIn addition\, in accordance with the Warrant Agreement\, Lucid’s board of directors has elected to require that\, upon delivery of the notice of redemption\, all Public Warrants are to be exercised only on a “cashless basis.” Accordingly\, holders may no longer exercise Public Warrants and receive Class A common stock in exchange for payment in cash of the $11.50 per warrant exercise price. Instead\, a holder exercising a Public Warrant will be deemed to pay the $11.50 per warrant exercise price by the surrender of 0.5542 of a share of Class A common stock (such fraction determined as described below) that such holder would have been entitled to receive upon a cash exercise of a Public Warrant. Accordingly\, by virtue of the cashless exercise of the Public Warrants\, exercising warrant holders will receive 0.4458 of a share of Class A common stock for each Public Warrant surrendered for exercise. \n\n\n\nThe number of shares of Class A common stock that each exercising warrant holder will receive by virtue of the cashless exercise (instead of paying the $11.50 per Public Warrant cash exercise price) was calculated in accordance with the terms of the Warrant Agreement and is equal to the quotient obtained by dividing (x) the product of the number of shares underlying the Public Warrants held by such warrant holder\, multiplied by the difference between $20.751\, the average last sale price of the Class A common stock for the ten trading days ending on September 2\, 2021\, the third trading day prior to the date of the redemption notice (the “Fair Market Value”) and $11.50\, by (y) the Fair Market Value. If any holder of Public Warrants would\, after taking into account all of such holder’s Public Warrants exercised at one time\, be entitled to receive a fractional interest in a share of Class A common stock\, the number of shares the holder will be entitled to receive will be rounded down to the nearest whole number of shares. \n\n\n\nQuestions concerning redemption and exercise of the Public Warrants can be directed to Equiniti Trust Company\, P.O. Box 64874\, St. Paul\, MN 55164-0874\, Attention: EQ Shareowner Services\, telephone number (833) 914-2119.  \n\n\n\nAbout Lucid GroupLucid seeks to inspire the adoption of sustainable energy by creating the most captivating electric vehicles\, centered around the human experience. The company’s first car\, Lucid Air\, is a state-of-the-art luxury sedan with a California-inspired design underpinned by race-proven technology. Featuring luxurious interior space in a mid-size exterior footprint\, select models of Air are expected to be capable of a projected EPA estimated range of over 500 miles. Customer deliveries of Lucid Air are planned to begin this year. \n\n\n\nMedia Contactmedia@lucidmotors.com \n\n\n\nTrademarks \n\n\n\nThis communication contains trademarks\, service marks\, trade names and copyrights of Lucid Group\, Inc. and its affiliates (the “Company”) and other companies\, which are the property of their respective owners. \n\n\n\nForward-Looking Statements \n\n\n\nThis communication includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “estimate\,” “plan\,” “project\,” “forecast\,” “intend\,” “will\,” “expect\,” “anticipate\,” “believe\,” “seek\,” “target\,” “continue\,” “could\,” “may\,” “might\,” “possible\,” “potential\,” “predict” or other similar expressions that predict or indicate future events or trends or that are not statements of historical facts. These forward-looking statements include\, but are not limited to\, statements regarding the Company’s expectations and timing related to the start of production and deliveries of the Lucid Air and the performance\, range\, and other features of the Lucid Air.  These statements are based on various assumptions\, and actual events and circumstances may differ. Forward-looking statements are subject to a number of risks and uncertainties\, including factors discussed in the Company’s Registration Statement on Form S-1\, the Company’s Annual Report on Form 10-K/A for the year ended December 31\, 2020 and the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30\, 2021\, in each case\, under the heading “Risk Factors\,” as well as other documents of the Company that are filed\, or will be filed\, with the Securities and Exchange Commission. If any of these risks materialize or the Company’s assumptions prove incorrect\, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that the Company does not presently know or that the Company currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition\, forward-looking statements reflect the Company’s expectations\, plans or forecasts of future events and views as of the date of this communication. However\, while the Company may elect to update these forward-looking statements at some point in the future\, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s assessments as of any date subsequent to the date of this communication. \n\n\n\nSOURCE Lucid Motors \n\n\n\n\n\n\n\nRelated Links\n\n\n\nhttp://www.lucidmotors.com
URL:https://commonstockwarrants.com/event/lucid-motors-announces-redemption-of-outstanding-public-warrants-nsdq-lcid-lcidw-begin/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/08/LCID_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210927T080000
DTEND;TZID=America/New_York:20210927T170000
DTSTAMP:20260415T182625
CREATED:20210928T031636Z
LAST-MODIFIED:20210928T031651Z
UID:692041-1632729600-1632762000@commonstockwarrants.com
SUMMARY:Proterra (NASDAQ: PRTA\, PTRAW) Announces Redemption of Public Warrants and Private Placement Warrants - BEGIN
DESCRIPTION:BURLINGAME\, Calif.\, Sept. 27\, 2021 (GLOBE NEWSWIRE) — Proterra Inc (Nasdaq: PTRA) today announced that it will redeem all of its public warrants (the “Public Warrants”) and private placement warrants (the “Private Placement Warrants” and\, together with the Public Warrants\, the “Warrants”) to purchase shares of Proterra’s common stock (the “Common Stock”) that are governed by the Amended and Restated Warrant Agreement\, dated as of June 14\, 2021 (the “Warrant Agreement”)\, by and among Proterra\, Computershare Trust Company\, N.A.\, a federally chartered trust company\, and Computershare Inc.\, a Delaware corporation (collectively\, “Computershare”)\, as warrant agent and transfer agent\, and that remain outstanding following 5:00 p.m. New York City time on October 27\, 2021 (the “Redemption Date”) for a redemption price of $0.10 per Warrant (the “Redemption Price”). \n\n\n\nUnder the terms of the Warrant Agreement\, Proterra is entitled to redeem all of the outstanding Public Warrants at a redemption price of $0.10 per Public Warrant if the last reported sales price (the “Reference Value”) of the Common Stock is at least $10.00 per share on any twenty trading days within the thirty trading day period ending on the third trading day prior to the date on which a notice of redemption is given and (ii) if the Reference Value is less than $18.00 per share\, the Private Placement Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants. This share price performance requirement was satisfied as of September 22\, 2021.   Computershare\, in its capacity as warrant agent\, has delivered a notice of redemption (the “Redemption Notice”) to each of the registered holders of such outstanding Warrants on behalf of Proterra. \n\n\n\nAll Warrants may be exercised by the holders thereof until 5:00 p.m. New York City time on the Redemption Date.   As the Reference Value is less than $18.00 per share\, payment upon exercise of the Warrants may be made either (i) in cash\, at an exercise price of $11.50 per share of Common Stock (the “Cash Exercise Price”) or (ii) on a “cashless basis” in which the exercising holder will receive a number of shares of Common Stock to be determined in accordance with the terms of the Warrant Agreement and based on the Redemption Date and the volume weighted average price (the “Fair Market Value”) of the Common Stock during the 10 trading days immediately following the date on which the Redemption Notice is sent to holders of Warrants. Proterra will inform holders of the Fair Market Value no later than one business day after such 10-trading day period ends. In no event will the number of shares of Common Stock issued in connection with an exercise on a cashless basis exceed 0.361 shares of Common Stock per Warrant. If any holder of Warrants would\, after taking into account all of such holder’s Warrants exercised at one time\, be entitled to receive a fractional interest in a share of Common Stock\, the number of shares the holder will be entitled to receive will be rounded down to the nearest whole number of shares. \n\n\n\nAny Warrants that remain unexercised following 5:00 p.m. New York City time on the Redemption Date will be void and no longer exercisable\, and the holders of those Warrants will be entitled to receive only the Redemption Price. \n\n\n\nThe shares of Common Stock issuable upon exercise of the Warrants have been registered by Proterra under the Securities Act of 1933\, as amended\, and are covered by a registration statement filed on Form S-1 with\, and declared effective by\, the Securities and Exchange Commission (Registration No. 333-253079). \n\n\n\nQuestions concerning redemption and exercise of the Warrants can be directed to Georgeson\, 1290 Avenue of the Americas\, 9th Floor\, New York\, NY 10104\, telephone number 800-932-9864. \n\n\n\nFor a copy of the Redemption Notice\, please visit our investor relations website at https://ir.proterra.com.  \n\n\n\nThis press release shall not constitute an offer to sell or the solicitation of an offer to buy any Proterra securities and shall not constitute an offer\, solicitation or sale in any jurisdiction in which such offering\, solicitation or sale would be unlawful. \n\n\n\nAbout Proterra \n\n\n\nProterra is a leader in the design and manufacture of zero-emission electric transit vehicles and EV technology solutions for commercial applications. With industry-leading durability and energy efficiency based on rigorous U.S. independent testing\, Proterra products are proudly designed\, engineered\, and manufactured in America\, with offices in Silicon Valley\, South Carolina\, and Los Angeles. \n\n\n\nForward Looking Statements \n\n\n\nThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933\, as amended\, and Section 21E of the Securities Exchange Act of 1934\, as amended. Forward-looking statements include statements related to the redemption of the Warrants. Forward-looking statements are predictions\, projections and other statements about future events that are based on current expectations and assumptions and\, as a result\, are subject to significant risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release\, including risks and uncertainties set forth in the sections entitled “Risk Factors” in the Proterra’s prospectus dated July 9\, 2021 filed with the U.S. Securities and Exchange Commission (the “SEC”) on July 9\, 2021\, and Proterra’s annual and quarterly reports and other filings with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. The forward-looking statements included in this press release speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements\, and Proterra assumes no obligation and does not intend to update or revise these forward-looking statements\, whether as a result of new information\, future events\, or otherwise. Proterra does not give any assurance that it will achieve its expectations.
URL:https://commonstockwarrants.com/event/proterra-nasdaq-prta-ptraw-announces-redemption-of-public-warrants-and-private-placement-warrants-begin/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/09/PROTERRA_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211004T080000
DTEND;TZID=America/New_York:20211004T170000
DTSTAMP:20260415T182625
CREATED:20211004T105800Z
LAST-MODIFIED:20211006T111429Z
UID:692072-1633334400-1633366800@commonstockwarrants.com
SUMMARY:The Beauty Health Company (NASDAQ: SKIN\, SKINW) Announces Redemption of All Outstanding Warrants -BEGIN
DESCRIPTION:The Beauty Health Company (“BeautyHealth” or the “Company”; NASDAQ:SKIN)\, a global category-creator in beauty health leading the charge with its flagship brand HydraFacial\, today announced that the Company will redeem all of its outstanding warrants (the “Public Warrants”) to purchase shares of the Company’s Class A common stock\, par value $0.0001 per share (the “Common Stock”)\, that were issued under the Warrant Agreement\, dated September 29\, 2020\, by and between the Company and Continental Stock Transfer & Trust Company (the “Warrant Agent”)\, as warrant agent (the “Warrant Agreement”)\, as part of the units sold in the Company’s initial public offering (the “IPO”) and that remain outstanding at 5:00 p.m. New York City time on November 3\, 2021 (the “Redemption Date”) for a redemption price of $0.10 per Public Warrant. Warrants to purchase Common Stock that were issued under the Warrant Agreement in a private placement simultaneously with the IPO and that are still held by the initial holders thereof or their permitted transferees (the “Private Warrants”) are not subject to this redemption. \n\n\n\nUnder the terms of the Warrant Agreement\, the Company is entitled to redeem all of the outstanding Public Warrants at a redemption price of $0.10 per Public Warrant if (i) the last reported sales price (the “Reference Value”) of the Common Stock is at least $10.00 per share for any twenty trading days within the thirty-day trading period ending on the third trading day prior to the date on which a notice of redemption is given and (ii) if the Reference Value is less than $18.00 per share\, the Private Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants. At the direction of the Company\, the Warrant Agent has delivered a notice of redemption to each of the registered holders of the outstanding Public Warrants. \n\n\n\nThe Public Warrants may be exercised by the holders thereof until 5:00 p.m. New York City time on the Redemption Date to purchase fully paid and non-assessable shares of Common Stock underlying such Warrants. As the Company has called for redemption of the Public Warrants pursuant to Section 6.2 of the Warrant Agreement\, payment upon exercise of the Public Warrants may be made either (i) in cash\, at an exercise price of $11.50 per share of Common Stock or (ii) on a “cashless basis” in which the exercising holder will receive a number of shares of Common Stock to be determined in accordance with the terms of the Warrant Agreement and based on the Redemption Date and the volume weighted average price (the “Fair Market Value”) of the Common Stock during the 10 trading days immediately following the date on which the notice of redemption is sent to holders of Public Warrants. The Company will inform holders of the Fair Market Value no later than one business day after such 10-trading day period ends. In no event will the number of shares of Common Stock issued in connection with an exercise on a cashless basis exceed 0.361 shares of Common Stock per Public Warrant. If any holder of Public Warrants would\, after taking into account all of such holder’s Public Warrants exercised at one time\, be entitled to receive a fractional interest in a share of Common Stock\, the number of shares the holder will be entitled to receive will be rounded down to the nearest whole number of shares. \n\n\n\nAny Public Warrants that remain unexercised at 5:00 p.m. New York City time on the Redemption Date will be void and no longer exercisable\, and the holders of those Public Warrants will be entitled to receive only the redemption price of $0.10 per Public Warrant. \n\n\n\nNone of the Company\, its board of directors or employees has made or is making any representation or recommendation to any holder of the Public Warrants as to whether to exercise or refrain from exercising any Public Warrants. \n\n\n\nThe shares of Common Stock underlying the Public Warrants have been registered by the Company under the Securities Act of 1933\, as amended\, and are covered by a registration statement filed on Form S-1 with\, and declared effective by\, the Securities and Exchange Commission (Registration No. 333-257995). The SEC maintains an Internet website that contains a copy of this prospectus. The address of that site is www.sec.gov. Alternatively\, you can obtain a copy of the prospectus from the Company’s investor relations website at https://investors.beautyhealth.com/. \n\n\n\nQuestions concerning redemption and exercise of the Public Warrants can be directed to our information agent\, Morrow Sodali LLC\, at 470 West Avenue\, Stamford\, CT 06902\, telephone number: (800) 662-5200 or email: SKIN.info@investor.morrowsodali.com. \n\n\n\nNo Offer or Solicitation \n\n\n\nThis press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any offer of any of the Company’s securities in any jurisdiction in which such offer\, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. \n\n\n\nAbout The Beauty Health Company \n\n\n\nBeautyHealth is a category-creating beauty health company focused on bringing innovative products to market. Our flagship brand\, HydraFacial\, is a non-invasive and approachable beauty health platform and ecosystem with a powerful community of estheticians\, consumers and partners\, bridging medical and consumer retail to democratize and personalize skin care solutions for the masses. Leading the charge in beauty health as a category-creator\, HydraFacial uses a unique delivery system to cleanse\, extract\, and hydrate with their patented hydradermabrasion technology and super serums that are made with nourishing ingredients\, providing an immediate outcome and creating an instantly gratifying glow in just three steps and 30 minutes. HydraFacial® and Perk™ products are available in over 87 countries with over 18\,000 Delivery Systems globally and millions of treatments performed each year. \n\n\n\nForward-Looking Statements \n\n\n\nCertain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release\, the words “estimates\,” “projected\,” “expects\,” “anticipates\,” “forecasts\,” “plans\,” “intends\,” “believes\,” “seeks\,” “may\,” “will\,” “should\,” “future\,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. The absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions\, projections and other statements about future events that are based on current expectations and assumptions and\, as a result\, are subject to risks\, uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this document\, including but not limited to the risks and uncertainties set forth in the Company’s filings with the U.S. Securities and Exchange Commission. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements\, and the Company assumes no obligation and does not intend to update or revise these forward-looking statements\, whether as a result of new information\, future events\, or otherwise. \n\n\n\nView source version on businesswire.com:https://www.businesswire.com/news/home/20211004005846/en/ \n\n\n\nCONTACT: ICR\, Inc. \n\n\n\nInvestors: Dawn Francfort \n\n\n\nEmail:BeautyHealthIR@icrinc.comPress: Alecia Pulman \n\n\n\nEmail:alecia.pulman@icrinc.com \n\n\n\nKEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA \n\n\n\nINDUSTRY KEYWORD: HEALTH LUXURY COSMETICS RETAIL FITNESS & NUTRITION \n\n\n\nSOURCE: The Beauty Health Company \n\n\n\nCopyright Business Wire 2021. \n\n\n\nPUB: 10/04/2021 04:01 PM/DISC: 10/04/2021 04:02 PM \n\n\n\nhttp://www.businesswire.com/news/home/20211004005846/en
URL:https://commonstockwarrants.com/event/the-beauty-health-company-nasdaq-skin-skinw-announces-redemption-of-all-outstanding-warrants-begin/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/10/SKIN_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211008T080000
DTEND;TZID=America/New_York:20211008T170000
DTSTAMP:20260415T182625
CREATED:20210908T124449Z
LAST-MODIFIED:20210928T033028Z
UID:691841-1633680000-1633712400@commonstockwarrants.com
SUMMARY:Lucid Motors Announces Redemption of Outstanding Public Warrants (NSDQ: LCID\, LCIDW) -END
DESCRIPTION:NEWARK\, Calif.\, Sept. 8\, 2021 /PRNewswire/ — Lucid Group\, which is setting new standards with its advanced luxury EVs\, today announced that the Company will redeem all of its outstanding public warrants (the “Public Warrants”) to purchase shares of the Company’s Class A common stock that were issued under the Warrant Agreement dated July 29\, 2020 by and between the Company and Continental Stock Transfer & Trust Company as warrant agent (as assigned to and assumed by the Company and Equiniti Trust Company\, as transfer agent and warrant agent)\, as part of the units sold in the Company’s initial public offering (the “IPO”)\, for a redemption price of $0.01 per Public Warrant (the “Redemption Price”) that remain outstanding at 5:00 p.m. Eastern Time on October 8\, 2021 (the “Redemption Date”).   \n\n\n\n“We are pleased to announce the cashless redemption of our public warrants\,” said Peter Rawlinson\, CEO & CTO of Lucid Group. “This is an important milestone in streamlining our capital structure to eliminate outstanding public warrants at the same time as we see growing confidence in Lucid’s ground-breaking\, in-house developed electric vehicle technology\, which will soon arrive into the market in Lucid Air. Lucid has chosen in part to require cashless exercise of the Public Warrants to enable warrant holders\, including our retail investors\, to hold shares in Lucid without cash exercise. We also expect this action will minimize dilution from these public warrants.” \n\n\n\nThe Public Warrants are listed on Nasdaq under the symbol “LCIDW.” Each Public Warrant entitles the holder thereof to purchase one share of Class A common stock for a purchase price of $11.50 per share\, subject to adjustments (the “Exercise Price”). Under the terms of the Warrant Agreement\, Lucid is entitled to redeem all of the outstanding Public Warrants if the last sale price of the Class A common stock is at least $18.00 per share on each of twenty trading days within any thirty-day trading period ending on the third trading day prior to the date on which a notice of redemption is given. Lucid has directed the warrant agent to deliver a notice of redemption to each of the registered holders of the outstanding Public Warrants. Warrants to purchase Class A common stock that were issued under the Warrant Agreement in a private placement simultaneously with the IPO and still held by the initial holders thereof or their permitted transferees are not subject to this notice of redemption. \n\n\n\nThe Public Warrants will cease trading on Nasdaq at 5:00 pm Eastern Time on the Redemption Date. Any Public Warrants that remain unexercised at 5:00 pm Eastern Time on the Redemption Date will be delisted\, void and no longer exercisable\, and their holders will have no rights with respect to those Public Warrants except to receive the Redemption Price or as otherwise described in the redemption notice for holders who hold their Public Warrants in “street name.” \n\n\n\nIn addition\, in accordance with the Warrant Agreement\, Lucid’s board of directors has elected to require that\, upon delivery of the notice of redemption\, all Public Warrants are to be exercised only on a “cashless basis.” Accordingly\, holders may no longer exercise Public Warrants and receive Class A common stock in exchange for payment in cash of the $11.50 per warrant exercise price. Instead\, a holder exercising a Public Warrant will be deemed to pay the $11.50 per warrant exercise price by the surrender of 0.5542 of a share of Class A common stock (such fraction determined as described below) that such holder would have been entitled to receive upon a cash exercise of a Public Warrant. Accordingly\, by virtue of the cashless exercise of the Public Warrants\, exercising warrant holders will receive 0.4458 of a share of Class A common stock for each Public Warrant surrendered for exercise. \n\n\n\nThe number of shares of Class A common stock that each exercising warrant holder will receive by virtue of the cashless exercise (instead of paying the $11.50 per Public Warrant cash exercise price) was calculated in accordance with the terms of the Warrant Agreement and is equal to the quotient obtained by dividing (x) the product of the number of shares underlying the Public Warrants held by such warrant holder\, multiplied by the difference between $20.751\, the average last sale price of the Class A common stock for the ten trading days ending on September 2\, 2021\, the third trading day prior to the date of the redemption notice (the “Fair Market Value”) and $11.50\, by (y) the Fair Market Value. If any holder of Public Warrants would\, after taking into account all of such holder’s Public Warrants exercised at one time\, be entitled to receive a fractional interest in a share of Class A common stock\, the number of shares the holder will be entitled to receive will be rounded down to the nearest whole number of shares. \n\n\n\nQuestions concerning redemption and exercise of the Public Warrants can be directed to Equiniti Trust Company\, P.O. Box 64874\, St. Paul\, MN 55164-0874\, Attention: EQ Shareowner Services\, telephone number (833) 914-2119.  \n\n\n\nAbout Lucid GroupLucid seeks to inspire the adoption of sustainable energy by creating the most captivating electric vehicles\, centered around the human experience. The company’s first car\, Lucid Air\, is a state-of-the-art luxury sedan with a California-inspired design underpinned by race-proven technology. Featuring luxurious interior space in a mid-size exterior footprint\, select models of Air are expected to be capable of a projected EPA estimated range of over 500 miles. Customer deliveries of Lucid Air are planned to begin this year. \n\n\n\nMedia Contactmedia@lucidmotors.com \n\n\n\nTrademarks \n\n\n\nThis communication contains trademarks\, service marks\, trade names and copyrights of Lucid Group\, Inc. and its affiliates (the “Company”) and other companies\, which are the property of their respective owners. \n\n\n\nForward-Looking Statements \n\n\n\nThis communication includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “estimate\,” “plan\,” “project\,” “forecast\,” “intend\,” “will\,” “expect\,” “anticipate\,” “believe\,” “seek\,” “target\,” “continue\,” “could\,” “may\,” “might\,” “possible\,” “potential\,” “predict” or other similar expressions that predict or indicate future events or trends or that are not statements of historical facts. These forward-looking statements include\, but are not limited to\, statements regarding the Company’s expectations and timing related to the start of production and deliveries of the Lucid Air and the performance\, range\, and other features of the Lucid Air.  These statements are based on various assumptions\, and actual events and circumstances may differ. Forward-looking statements are subject to a number of risks and uncertainties\, including factors discussed in the Company’s Registration Statement on Form S-1\, the Company’s Annual Report on Form 10-K/A for the year ended December 31\, 2020 and the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30\, 2021\, in each case\, under the heading “Risk Factors\,” as well as other documents of the Company that are filed\, or will be filed\, with the Securities and Exchange Commission. If any of these risks materialize or the Company’s assumptions prove incorrect\, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that the Company does not presently know or that the Company currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition\, forward-looking statements reflect the Company’s expectations\, plans or forecasts of future events and views as of the date of this communication. However\, while the Company may elect to update these forward-looking statements at some point in the future\, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s assessments as of any date subsequent to the date of this communication. \n\n\n\nSOURCE Lucid Motors \n\n\n\n\n\n\n\nRelated Links\n\n\n\nhttp://www.lucidmotors.com
URL:https://commonstockwarrants.com/event/lucid-motors-announces-redemption-of-outstanding-public-warrants-nsdq-lcid-lcidw-end/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/08/LCID_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211013T080000
DTEND;TZID=America/New_York:20211013T170000
DTSTAMP:20260415T182625
CREATED:20211014T054755Z
LAST-MODIFIED:20211014T054806Z
UID:692112-1634112000-1634144400@commonstockwarrants.com
SUMMARY:Janus International Group\, Inc. (NYSE: JBI\, JBI.WS) Announces Redemption of Warrants -BEGIN
DESCRIPTION:TEMPLE\, Ga.–(BUSINESS WIRE)–Janus International Group\, Inc. (NYSE: JBI) (“Janus” or the “Company”) today announced that the Company will redeem all of its outstanding warrants (the “Warrants”) to purchase shares of the Company’s common stock\, par value $0.0001 per share (the “Common Stock”)\, that were issued under the Warrant Agreement\, dated as of June 7\, 2021 by and between the Company (f/k/a Juniper Industrial Holdings\, Inc.) and Continental Stock Transfer & Trust Company (the “Warrant Agent”) and the Warrant Agreement\, dated as of July 15\, 2021\, by and between the Company and the Warrant Agent (together\, the “Warrant Agreements”)\, for a redemption price of $0.10 per Warrant (the “Redemption Price”)\, that remain outstanding at 5:00 p.m. New York City time on November 12\, 2021 (the “Redemption Date”). \n\n\n\nUnder the terms of the Warrant Agreements\, the Company is entitled to redeem all of the outstanding Warrants if the last sales price of the Common Stock has been at least $10.00 per share on the trading day prior to the date on which a notice of redemption is given. This share price performance target has been met. At the direction of the Company\, the Warrant Agent has delivered a notice of redemption to each of the registered holders of the outstanding Warrants. \n\n\n\nIn accordance with the Warrant Agreements\, upon delivery of the notice of redemption\, the Warrants may be exercised either for cash or on a “cashless basis.” Accordingly\, holders may continue to exercise Warrants and receive Common Stock in exchange for payment in cash of the $11.50 per warrant exercise price. Alternatively\, a holder may surrender Warrants for a certain number of a share of Common Stock (such fraction determined by reference to the Warrant Agreements and described in the notice of redemption) that such holder would have been entitled to receive upon a cash exercise of a Warrant. Holders of warrants that elect a “make-whole” cashless exercise of the Warrants will receive 0.3 of a share of Common Stock for each Warrant surrendered for exercise. The exercise procedures are described in the notice of redemption and the election to purchase included therein. Any Warrants that remain unexercised at 5:00 p.m. New York City time on the Redemption Date will be delisted\, void and no longer exercisable\, and the holders will have no rights with respect to those Warrants\, except to receive the Redemption Price. \n\n\n\nThe number of shares of Common Stock that each exercising warrant holder will receive by virtue of the make-whole cashless exercise (instead of paying the $11.50 per Warrant cash exercise price) was calculated in accordance with the terms of the Warrant Agreements with reference to the table set forth in Section 6.2 of the Warrant Agreements based on the fair market value of the shares of Common Stock and length of time to the applicable expiration of the Warrants. If any holder of Warrants would\, after taking into account all of such holder’s Warrants exercised at one time\, be entitled to receive a fractional interest in a share of Common Stock\, the number of shares the holder will be entitled to receive will be rounded down to the nearest whole number of shares. \n\n\n\nJanus understands from the New York Stock Exchange that November 11\, 2021\, the trading day prior to the Redemption Date\, will be the last day on which the Warrants will be traded on the New York Stock Exchange. \n\n\n\nNone of Janus\, its board of directors or employees has made or is making any representation or recommendation to any holder of the Warrants as to whether to exercise\, whether on a cash or cashless basis\, or refrain from exercising any Warrants. \n\n\n\nIssuance of the shares of Common Stock underlying the Warrants has been registered by Janus under the Securities Act of 1933\, as amended\, and is covered by a registration statement filed on Form S-1 with\, and declared effective by\, the Securities and Exchange Commission (Registration No. 333-257731). Exercise of Warrants held in “street name” should be directed through the broker of the warrant holder. In addition to the broker\, questions may also be directed to Continental Stock Transfer & Trust Company\, 1 State Street\, 30th Floor\, New York\, New York 10004\, Attention: Compliance Department\, Telephone Number (212) 509-4000 or to Morrow Sodali at (800) 662-5200 (for individuals) / (203) 658-9400 (for banks and brokerages) or by email at JBI@info.morrowsodali.com. \n\n\n\nAdditional information can be found on Janus’ Investor Relations website: https://ir.janusintl.com/. \n\n\n\nAbout Janus International Group \n\n\n\nJanus International Group\, Inc. (www.JanusIntl.com) is a leading global manufacturer and supplier of turn-key self-storage\, commercial and industrial building solutions\, including: roll-up and swing doors\, hallway systems\, re-locatable storage units and facility and door automation technologies. The Janus team operates out of several U.S. locations and six locations internationally. \n\n\n\nNo Offer or Solicitation \n\n\n\nThis communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval\, nor shall there be any sale of any securities in any state or jurisdiction in which such offer\, solicitation\, or sale would be unlawful prior to registration or qualification under the securities laws of such other jurisdiction. \n\n\n\nForward Looking Statements \n\n\n\nCertain statements in this communication may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933\, as amended\, and Section 21E of the Securities Exchange Act of 1934\, as amended. All statements other than statements of historical fact included in this communication are forward-looking statements. When used in this communication\, words such as “may\,” “should\,” “could\,” “would\,” “expect\,” “plan\,” “anticipate\,” “believe\,” “estimate\,” “continue\,” or the negative of such terms or other similar expressions\, as they relate to the management team\, identify forward-looking statements. Such forward-looking statements are based on the current beliefs of Janus’ management\, based on currently available information\, as to the outcome and timing of future events\, and involve factors\, risks\, and uncertainties that may cause actual results in future periods to differ materially from such statements. \n\n\n\nIn addition to factors previously disclosed in Janus’ reports filed with the SEC and those identified elsewhere in this communication\, the following factors\, among others\, could cause actual results to differ materially from forward-looking statements or historical performance: (i) risks of the self-storage industry; (ii) the highly competitive nature of the self-storage industry and Janus’ ability to compete therein; and (iii) the risk that the demand outlook for Janus’ products may not be as strong as anticipated. \n\n\n\nThere can be no assurance that the events\, results\, trends or guidance regarding financial outlook identified in these forward-looking statements will occur or be achieved. Forward-looking statements speak only as of the date they are made\, and Janus is not under any obligation and expressly disclaims any obligation\, to update\, alter or otherwise revise any forward-looking statement\, whether as a result of new information\, future events or otherwise\, except as required by law. This communication is not intended to be all-inclusive or to contain all the information that a person may desire in considering an investment in Janus and is not intended to form the basis of an investment decision in Janus. All subsequent written and oral forward-looking statements concerning Janus or other matters and attributable to Janus or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above and under the heading “Risk Factors” in Janus’ Quarterly Report on Form 10-Q filed with the SEC on August 10\, 2021 and in Janus’ other filings. \n\n\n\n\n\n\n\nContacts\n\n\n\nInvestor Contacts\, JanusRodny Nacier / Dan ScottIR@janusintl.com(770) 562-6399Media Contacts\, JanusBethany MorehouseMarketing Content Manager\, Janus International770-746-9576Marketing@Janusintl.comMargot Olcay\, ICRMargot.Olcay@ICRinc.com
URL:https://commonstockwarrants.com/event/janus-international-group-inc-nyse-jbi-jbi-ws-announces-redemption-of-warrants-begin/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/10/JANUS_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211027T170000
DTEND;TZID=America/New_York:20211027T170000
DTSTAMP:20260415T182625
CREATED:20210928T031714Z
LAST-MODIFIED:20210928T031736Z
UID:692042-1635354000-1635354000@commonstockwarrants.com
SUMMARY:Proterra (NASDAQ: PRTA\, PTRAW) Closes Redemption of Public Warrants and Private Placement Warrants - END
DESCRIPTION:BURLINGAME\, Calif.\, Sept. 27\, 2021 (GLOBE NEWSWIRE) — Proterra Inc (Nasdaq: PTRA) today announced that it will redeem all of its public warrants (the “Public Warrants”) and private placement warrants (the “Private Placement Warrants” and\, together with the Public Warrants\, the “Warrants”) to purchase shares of Proterra’s common stock (the “Common Stock”) that are governed by the Amended and Restated Warrant Agreement\, dated as of June 14\, 2021 (the “Warrant Agreement”)\, by and among Proterra\, Computershare Trust Company\, N.A.\, a federally chartered trust company\, and Computershare Inc.\, a Delaware corporation (collectively\, “Computershare”)\, as warrant agent and transfer agent\, and that remain outstanding following 5:00 p.m. New York City time on October 27\, 2021 (the “Redemption Date”) for a redemption price of $0.10 per Warrant (the “Redemption Price”). \n\n\n\nUnder the terms of the Warrant Agreement\, Proterra is entitled to redeem all of the outstanding Public Warrants at a redemption price of $0.10 per Public Warrant if the last reported sales price (the “Reference Value”) of the Common Stock is at least $10.00 per share on any twenty trading days within the thirty trading day period ending on the third trading day prior to the date on which a notice of redemption is given and (ii) if the Reference Value is less than $18.00 per share\, the Private Placement Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants. This share price performance requirement was satisfied as of September 22\, 2021.   Computershare\, in its capacity as warrant agent\, has delivered a notice of redemption (the “Redemption Notice”) to each of the registered holders of such outstanding Warrants on behalf of Proterra. \n\n\n\nAll Warrants may be exercised by the holders thereof until 5:00 p.m. New York City time on the Redemption Date.   As the Reference Value is less than $18.00 per share\, payment upon exercise of the Warrants may be made either (i) in cash\, at an exercise price of $11.50 per share of Common Stock (the “Cash Exercise Price”) or (ii) on a “cashless basis” in which the exercising holder will receive a number of shares of Common Stock to be determined in accordance with the terms of the Warrant Agreement and based on the Redemption Date and the volume weighted average price (the “Fair Market Value”) of the Common Stock during the 10 trading days immediately following the date on which the Redemption Notice is sent to holders of Warrants. Proterra will inform holders of the Fair Market Value no later than one business day after such 10-trading day period ends. In no event will the number of shares of Common Stock issued in connection with an exercise on a cashless basis exceed 0.361 shares of Common Stock per Warrant. If any holder of Warrants would\, after taking into account all of such holder’s Warrants exercised at one time\, be entitled to receive a fractional interest in a share of Common Stock\, the number of shares the holder will be entitled to receive will be rounded down to the nearest whole number of shares. \n\n\n\nAny Warrants that remain unexercised following 5:00 p.m. New York City time on the Redemption Date will be void and no longer exercisable\, and the holders of those Warrants will be entitled to receive only the Redemption Price. \n\n\n\nThe shares of Common Stock issuable upon exercise of the Warrants have been registered by Proterra under the Securities Act of 1933\, as amended\, and are covered by a registration statement filed on Form S-1 with\, and declared effective by\, the Securities and Exchange Commission (Registration No. 333-253079). \n\n\n\nQuestions concerning redemption and exercise of the Warrants can be directed to Georgeson\, 1290 Avenue of the Americas\, 9th Floor\, New York\, NY 10104\, telephone number 800-932-9864. \n\n\n\nFor a copy of the Redemption Notice\, please visit our investor relations website at https://ir.proterra.com.  \n\n\n\nThis press release shall not constitute an offer to sell or the solicitation of an offer to buy any Proterra securities and shall not constitute an offer\, solicitation or sale in any jurisdiction in which such offering\, solicitation or sale would be unlawful. \n\n\n\nAbout Proterra \n\n\n\nProterra is a leader in the design and manufacture of zero-emission electric transit vehicles and EV technology solutions for commercial applications. With industry-leading durability and energy efficiency based on rigorous U.S. independent testing\, Proterra products are proudly designed\, engineered\, and manufactured in America\, with offices in Silicon Valley\, South Carolina\, and Los Angeles. \n\n\n\nForward Looking Statements \n\n\n\nThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933\, as amended\, and Section 21E of the Securities Exchange Act of 1934\, as amended. Forward-looking statements include statements related to the redemption of the Warrants. Forward-looking statements are predictions\, projections and other statements about future events that are based on current expectations and assumptions and\, as a result\, are subject to significant risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release\, including risks and uncertainties set forth in the sections entitled “Risk Factors” in the Proterra’s prospectus dated July 9\, 2021 filed with the U.S. Securities and Exchange Commission (the “SEC”) on July 9\, 2021\, and Proterra’s annual and quarterly reports and other filings with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. The forward-looking statements included in this press release speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements\, and Proterra assumes no obligation and does not intend to update or revise these forward-looking statements\, whether as a result of new information\, future events\, or otherwise. Proterra does not give any assurance that it will achieve its expectations.
URL:https://commonstockwarrants.com/event/proterra-nasdaq-prta-ptraw-announces-redemption-of-public-warrants-and-private-placement-warrants-2/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/09/PROTERRA_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211103T080000
DTEND;TZID=America/New_York:20211103T170000
DTSTAMP:20260415T182625
CREATED:20211004T111500Z
LAST-MODIFIED:20211006T112151Z
UID:692073-1635926400-1635958800@commonstockwarrants.com
SUMMARY:The Beauty Health Company (NASDAQ: SKIN\, SKINW) Completes Redemption of All Outstanding Warrants -END
DESCRIPTION:The Beauty Health Company (“BeautyHealth” or the “Company”; NASDAQ:SKIN)\, a global category-creator in beauty health leading the charge with its flagship brand HydraFacial\, today announced that the Company will redeem all of its outstanding warrants (the “Public Warrants”) to purchase shares of the Company’s Class A common stock\, par value $0.0001 per share (the “Common Stock”)\, that were issued under the Warrant Agreement\, dated September 29\, 2020\, by and between the Company and Continental Stock Transfer & Trust Company (the “Warrant Agent”)\, as warrant agent (the “Warrant Agreement”)\, as part of the units sold in the Company’s initial public offering (the “IPO”) and that remain outstanding at 5:00 p.m. New York City time on November 3\, 2021 (the “Redemption Date”) for a redemption price of $0.10 per Public Warrant. Warrants to purchase Common Stock that were issued under the Warrant Agreement in a private placement simultaneously with the IPO and that are still held by the initial holders thereof or their permitted transferees (the “Private Warrants”) are not subject to this redemption. \n\n\n\nUnder the terms of the Warrant Agreement\, the Company is entitled to redeem all of the outstanding Public Warrants at a redemption price of $0.10 per Public Warrant if (i) the last reported sales price (the “Reference Value”) of the Common Stock is at least $10.00 per share for any twenty trading days within the thirty-day trading period ending on the third trading day prior to the date on which a notice of redemption is given and (ii) if the Reference Value is less than $18.00 per share\, the Private Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants. At the direction of the Company\, the Warrant Agent has delivered a notice of redemption to each of the registered holders of the outstanding Public Warrants. \n\n\n\nThe Public Warrants may be exercised by the holders thereof until 5:00 p.m. New York City time on the Redemption Date to purchase fully paid and non-assessable shares of Common Stock underlying such Warrants. As the Company has called for redemption of the Public Warrants pursuant to Section 6.2 of the Warrant Agreement\, payment upon exercise of the Public Warrants may be made either (i) in cash\, at an exercise price of $11.50 per share of Common Stock or (ii) on a “cashless basis” in which the exercising holder will receive a number of shares of Common Stock to be determined in accordance with the terms of the Warrant Agreement and based on the Redemption Date and the volume weighted average price (the “Fair Market Value”) of the Common Stock during the 10 trading days immediately following the date on which the notice of redemption is sent to holders of Public Warrants. The Company will inform holders of the Fair Market Value no later than one business day after such 10-trading day period ends. In no event will the number of shares of Common Stock issued in connection with an exercise on a cashless basis exceed 0.361 shares of Common Stock per Public Warrant. If any holder of Public Warrants would\, after taking into account all of such holder’s Public Warrants exercised at one time\, be entitled to receive a fractional interest in a share of Common Stock\, the number of shares the holder will be entitled to receive will be rounded down to the nearest whole number of shares. \n\n\n\nAny Public Warrants that remain unexercised at 5:00 p.m. New York City time on the Redemption Date will be void and no longer exercisable\, and the holders of those Public Warrants will be entitled to receive only the redemption price of $0.10 per Public Warrant. \n\n\n\nNone of the Company\, its board of directors or employees has made or is making any representation or recommendation to any holder of the Public Warrants as to whether to exercise or refrain from exercising any Public Warrants. \n\n\n\nThe shares of Common Stock underlying the Public Warrants have been registered by the Company under the Securities Act of 1933\, as amended\, and are covered by a registration statement filed on Form S-1 with\, and declared effective by\, the Securities and Exchange Commission (Registration No. 333-257995). The SEC maintains an Internet website that contains a copy of this prospectus. The address of that site is www.sec.gov. Alternatively\, you can obtain a copy of the prospectus from the Company’s investor relations website at https://investors.beautyhealth.com/. \n\n\n\nQuestions concerning redemption and exercise of the Public Warrants can be directed to our information agent\, Morrow Sodali LLC\, at 470 West Avenue\, Stamford\, CT 06902\, telephone number: (800) 662-5200 or email: SKIN.info@investor.morrowsodali.com. \n\n\n\nNo Offer or Solicitation \n\n\n\nThis press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any offer of any of the Company’s securities in any jurisdiction in which such offer\, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. \n\n\n\nAbout The Beauty Health Company \n\n\n\nBeautyHealth is a category-creating beauty health company focused on bringing innovative products to market. Our flagship brand\, HydraFacial\, is a non-invasive and approachable beauty health platform and ecosystem with a powerful community of estheticians\, consumers and partners\, bridging medical and consumer retail to democratize and personalize skin care solutions for the masses. Leading the charge in beauty health as a category-creator\, HydraFacial uses a unique delivery system to cleanse\, extract\, and hydrate with their patented hydradermabrasion technology and super serums that are made with nourishing ingredients\, providing an immediate outcome and creating an instantly gratifying glow in just three steps and 30 minutes. HydraFacial® and Perk™ products are available in over 87 countries with over 18\,000 Delivery Systems globally and millions of treatments performed each year. \n\n\n\nForward-Looking Statements \n\n\n\nCertain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release\, the words “estimates\,” “projected\,” “expects\,” “anticipates\,” “forecasts\,” “plans\,” “intends\,” “believes\,” “seeks\,” “may\,” “will\,” “should\,” “future\,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. The absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions\, projections and other statements about future events that are based on current expectations and assumptions and\, as a result\, are subject to risks\, uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this document\, including but not limited to the risks and uncertainties set forth in the Company’s filings with the U.S. Securities and Exchange Commission. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements\, and the Company assumes no obligation and does not intend to update or revise these forward-looking statements\, whether as a result of new information\, future events\, or otherwise. \n\n\n\nView source version on businesswire.com:https://www.businesswire.com/news/home/20211004005846/en/ \n\n\n\nCONTACT: ICR\, Inc. \n\n\n\nInvestors: Dawn Francfort \n\n\n\nEmail:BeautyHealthIR@icrinc.comPress: Alecia Pulman \n\n\n\nEmail:alecia.pulman@icrinc.com \n\n\n\nKEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA \n\n\n\nINDUSTRY KEYWORD: HEALTH LUXURY COSMETICS RETAIL FITNESS & NUTRITION \n\n\n\nSOURCE: The Beauty Health Company \n\n\n\nCopyright Business Wire 2021. \n\n\n\nPUB: 10/04/2021 04:01 PM/DISC: 10/04/2021 04:02 PM \n\n\n\nhttp://www.businesswire.com/news/home/20211004005846/en
URL:https://commonstockwarrants.com/event/the-beauty-health-company-completes-redemption-of-all-outstanding-warrants-end/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/10/SKIN_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211104T080000
DTEND;TZID=America/New_York:20211104T170000
DTSTAMP:20260415T182625
CREATED:20211104T220000Z
LAST-MODIFIED:20211105T152849Z
UID:692260-1636012800-1636045200@commonstockwarrants.com
SUMMARY:SoFi Technologies\, Inc. (NASDAQ: SOFI\, SOFIW) Announces Redemption of All Outstanding Warrants - BEGIN
DESCRIPTION:SAN FRANCISCO–(BUSINESS WIRE)– SoFi Technologies\, Inc. (NASDAQ: SOFI)\, (“SoFi” or “the Company”)\, a leading digital personal finance company\, today announced that the Company will redeem all of its outstanding warrants (the “Public Warrants”) to purchase shares of the Company’s common stock\, par value $0.0001 per share (the “Common Stock”)\, that were issued under the Warrant Agreement\, dated October 8\, 2020\, by and between the Company and Continental Stock Transfer & Trust Company (“CST”)\, as warrant agent (the “Warrant Agent”)\, (the “Warrant Agreement”)\, as part of the units sold in the Company’s initial public offering (the “IPO”) and that remain outstanding at 5:00 p.m. New York City time on December 6\, 2021 (the “Redemption Date”) for a redemption price of $0.10 per Public Warrant. In addition\, the Company will redeem all of its outstanding warrants to purchase Common Stock that were issued under the Warrant Agreement in a private placement simultaneously with the IPO (the “Private Warrants” and\, together with the Public Warrants\, the “Warrants”) on the same terms as the outstanding Public Warrants. \n\n\n\nUnder the terms of the Warrant Agreement\, the Company is entitled to redeem all of the outstanding Public Warrants at a redemption price of $0.10 per Public Warrant if (i) the last sales price (the “Reference Value”) of the Common Stock equals or exceeds $10.00 per share on each of twenty trading days within any thirty-day trading period ending on the third trading day prior to the date on which a notice of redemption is given and (ii) if the Reference Value is less than $18.00 per share\, the Private Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants. At the direction of the Company\, the Warrant Agent has delivered a notice of redemption to each of the registered holders of the outstanding Warrants. \n\n\n\nThe Warrants may be exercised by the holders thereof until 5:00 p.m. New York City time on the Redemption Date to purchase fully paid and non-assessable shares of Common Stock underlying such Warrants. As the Reference Value is less than $18.00 per share\, payment upon exercise of the Warrants may be made either (i) in cash\, at an exercise price of $11.50 per share of Common Stock or (ii) on a “cashless basis” in which the exercising holder will receive a number of shares of Common Stock to be determined in accordance with the terms of the Warrant Agreement and based on the Redemption Date and the volume weighted average price (the “Fair Market Value”) of the Common Stock during the 10 trading days immediately following the date on which the notice of redemption is sent to holders of Warrants. The Company will provide holders the Fair Market Value no later than one business day after such 10-trading day period ends. In no event will the number of shares of Common Stock issued in connection with an exercise on a cashless basis exceed 0.361 shares of Common Stock per Warrant. If any holder of Warrants would\, after taking into account all of such holder’s Warrants exercised at one time\, be entitled to receive a fractional interest in a share of Common Stock\, the number of shares the holder will be entitled to receive will be rounded down to the nearest whole number of shares. \n\n\n\nAny Warrants that remain unexercised at 5:00 p.m. New York City time on the Redemption Date will be void and no longer exercisable\, and the holders of those Warrants will be entitled to receive only the redemption price of $0.10 per Warrant. \n\n\n\nNone of the Company\, its board of directors or employees has made or is making any representation or recommendation to any holder of the Warrants as to whether to exercise or refrain from exercising any Warrants. \n\n\n\nThe shares of Common Stock underlying the Warrants have been registered by the Company under the Securities Act of 1933\, as amended\, and are covered by a registration statement filed on Form S-1 with\, and declared effective by\, the Securities and Exchange Commission (Registration No. 333-257092). The SEC maintains an Internet website that contains a copy of this prospectus. The address of that site is www.sec.gov. Alternatively\, you can obtain a copy of the prospectus from the Company’s investor relations website at https://investors.sofi.com/overview/default.aspx. \n\n\n\nThis press release does not and will not constitute an offer to sell\, or the solicitation of an offer to buy\, the warrants\, any shares of SoFi’s common stock\, or any other securities\, nor will there be any sale of the warrants or any such shares or other securities\, in any state or other jurisdiction in which such offer\, sale or solicitation would be unlawful. \n\n\n\nAbout SoFi Technologies\, Inc. \n\n\n\nSoFi helps people achieve financial independence to realize their ambitions. Our products for borrowing\, saving\, spending\, investing and protecting give our more than two million members fast access to tools to get their money right. SoFi membership comes with the key essentials for getting ahead\, including career advisors and connection to a thriving community of like-minded\, ambitious people. SoFi is also the naming rights partner of SoFi Stadium\, home of the Los Angeles Chargers and the Los Angeles Rams. \n\n\n\nForward-Looking Statements \n\n\n\nThis press release includes forward-looking statements. Forward-looking statements represent SoFi’s current expectations regarding future events and are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those implied by the forward-looking statements\, and there can be no assurance that future developments affecting SoFi will be those that it has anticipated. Among those risks and uncertainties are market conditions\, including market interest rates\, the trading price and volatility of SoFi’s common stock and risks relating to SoFi’s business\, including those described in periodic reports that SoFi files from time to time with the Securities and Exchange Commission. The forward-looking statements included in this press release speak only as of the date of this press release\, and SoFi does not undertake to update the statements included in this press release for subsequent developments\, except as may be required by law. \n\n\n\nSOFI-F \n\n\n\n\n\n\n\nInvestors:Andrea ProchniakSoFiaprochniak@sofi.orgMedia:Rachel RosenzweigSoFirrosenzweig@sofi.orgSource: SoFi Technologies
URL:https://commonstockwarrants.com/event/sofi-technologies-inc-nasdaq-sofi-sofiw-announces-redemption-of-all-outstanding-warrants-begin/
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/11/SOFI_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211104T080000
DTEND;TZID=America/New_York:20211104T170000
DTSTAMP:20260415T182625
CREATED:20211104T225300Z
LAST-MODIFIED:20211115T120245Z
UID:692359-1636012800-1636045200@commonstockwarrants.com
SUMMARY:Archaea Energy Inc. (NYSE: LFG\, LFG.WS) Announces Redemption of All Outstanding Public Warrants - BEGIN
DESCRIPTION:HOUSTON–(BUSINESS WIRE)–Archaea Energy Inc. (“Archaea” or the “Company”) (NYSE: LFG) today announced that the Company will redeem all of its publicly held warrants (the “Public Warrants”) to purchase shares of the Company’s Class A common stock\, par value $0.0001 per share (the “Class A Common Stock”)\, that remain outstanding at 5:00 p.m.\, New York City time\, on December 6\, 2021 (the “Redemption Date”) for a redemption price of $0.10 per Public Warrant (the “Redemption Price”). The Public Warrants were issued under the Warrant Agreement\, dated October 21\, 2020 (the “Warrant Agreement”)\, by and among the Company\, LFG Acquisition Holdings LLC and Continental Stock Transfer & Trust Company\, as warrant agent (the “Warrant Agent”)\, as part of the units sold in the Company’s initial public offering (the “IPO”). \n\n\n\nIn addition\, the Company will redeem all of its warrants to purchase shares of Class A Common Stock that were issued to Atlas Point Energy Infrastructure Fund\, LLC (the “Forward Purchase Warrants” and\, together with the Public Warrants\, the “Redeemable Warrants”) in a private placement simultaneously with the consummation of the Company’s business combination on September 15\, 2021 (the “Business Combination”) that remain outstanding on the Redemption Date at the Redemption Price. \n\n\n\nUnder the terms of the Warrant Agreement\, the Company is entitled to redeem all 12.1 million outstanding Redeemable Warrants at a redemption price of $0.10 per Redeemable Warrant if the last reported sales price of the Class A Common Stock has been at least $10.00 per share on the trading day prior to the date on which the notice of redemption is given and provided that there is an effective registration statement covering the shares of Class A Common Stock issuable upon exercise of the Redeemable Warrants and a current prospectus relating thereto available throughout the 30-day redemption period. The Company has directed the Warrant Agent to deliver a notice of redemption to each of the registered holders of the outstanding Redeemable Warrants. \n\n\n\nPursuant to the Warrant Agreement\, the 6.8 million warrants to purchase Class A Common Stock that were issued in a private placement simultaneously with the IPO are not subject to this redemption as they are still held by the initial holders thereof. \n\n\n\nThe Redeemable Warrants may be exercised by the holders thereof until 5:00 p.m.\, New York City time\, on the Redemption Date (December 6\, 2021) to purchase shares of Class A Common Stock underlying such warrants. Holders may continue to exercise Redeemable Warrants and receive Class A Common Stock in exchange for payment in cash of the $11.50 per warrant exercise price. Alternatively\, a holder may elect to exercise their Redeemable Warrants on a “cashless basis” and surrender Redeemable Warrants for a certain number of shares of Class A Common Stock that is determined by reference to the table set forth in Section 6.2 of the Warrant Agreement based on the fair market value of the shares of Class A Common Stock and length of time to the expiration of the Redeemable Warrants. Holders of Redeemable Warrants that elect to exercise on such a cashless basis (instead of paying the $11.50 per warrant cash exercise price) will receive 0.361 shares of Class A Common Stock for each Redeemable Warrant surrendered for exercise. If any holder of Redeemable Warrants would\, after taking into account all of such holder’s Redeemable Warrants exercised at one time\, be entitled to receive a fractional interest in a share of Class A Common Stock\, the number of shares the holder will be entitled to receive will be rounded down to the nearest whole number of shares. The exercise procedures are described in the notice of redemption and the election to purchase included therein. \n\n\n\nTo minimize dilution to its existing stockholders as a result of warrant exercises\, the Company intends to use any cash proceeds received from exercises of its warrants to repurchase shares of Class A Common Stock from Aria Renewable Energy Systems LLC at a price of $17.65 per share. Aria Renewable Energy Systems LLC beneficially owns Class A units of LFG Acquisition Holdings LLC\, which are convertible into shares of Class A Common Stock\, as a result of the Business Combination. The net result of the redemption of Redeemable Warrants\, combined with such repurchase of shares\, is a maximum net share count increase of 4.4 million shares associated with the Redeemable Warrants. \n\n\n\nAny Redeemable Warrants that remain unexercised at 5:00 p.m.\, New York City time\, on the Redemption Date will be void and no longer exercisable\, and the holders of those Redeemable Warrants will be entitled to receive only the redemption price of $0.10 per Redeemable Warrant. Holders of Public Warrants held in “street name” should contact their broker to determine their broker’s procedure for exercising their Public Warrants. \n\n\n\nThe Company understands from the New York Stock Exchange (the “NYSE”) that December 3\, 2021\, the trading day prior to the Redemption Date\, will be the last day on which the Public Warrants will be traded on the NYSE. \n\n\n\nNone of the Company\, its board of directors or employees has made or is making any representation or recommendation to any holder of the Redeemable Warrants as to whether to exercise or refrain from exercising any Redeemable Warrants. \n\n\n\nThe shares of Class A Common Stock underlying the Redeemable Warrants have been registered by the Company under the Securities Act of 1933\, as amended\, and are covered by a Registration Statement on Form S-l (Registration No. 333-260094) filed with\, and declared effective by\, the Securities and Exchange Commission (the “Registration Statement”). \n\n\n\nQuestions concerning redemption or exercise of the Redeemable Warrants may be directed to the Company’s redemption information agent\, D.F. King & Co.\, Inc.\, Attention: Michael Horthman\, by calling (800) 848-3410 (or (212) 269-5550 for banks and brokers)\, or by emailing LFG@dfking.com. Questions may also be directed to the Warrant Agent\, Continental Stock Transfer & Trust Company\, at 1 State Street\, 30th Floor\, New York\, New York 10004\, Attention: Compliance Department\, or by calling (212) 509-4000. \n\n\n\nNo Offer or Solicitation \n\n\n\nThis press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any offer of any of the Company’s securities in any jurisdiction in which such offer\, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. \n\n\n\nAbout Archaea Energy Inc. \n\n\n\nArchaea Energy Inc. is one of the largest RNG producers in the U.S.\, with an industry leading RNG platform and expertise in developing\, constructing\, and operating RNG facilities to capture waste emissions and convert them into low carbon fuel. Archaea’s innovative\, technology-driven approach is backed by significant gas processing expertise\, enabling Archaea to deliver RNG projects that are expected to have higher uptime and efficiency\, and lower development costs and time to market\, than industry averages. Archaea partners with landfill and farm owners to help them transform their long-lived feedstock sources into RNG and convert their facilities into renewable energy centers. Archaea’s differentiated commercial strategy is focused on long-term contracts that provide commercial partners a reliable\, non-intermittent\, sustainable decarbonizing solution to displace fossil fuels in high-carbon emission processes and industries. \n\n\n\nForward Looking Statements \n\n\n\nCertain statements made in this release are “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933\, as amended\, and Section 21E of the Securities Exchange Act of 1934\, as amended. Forward-looking statements may be identified by the use of words such as “may\,” “might\,” “will\,” “would\,” “could\,” “should\,” “forecast\,” “intend\,” “seek\,” “target\,” “anticipate\,” “believe\,” “expect\,” “estimate\,” “plan\,” “outlook\,” and “project” and other similar expressions\, although not all forward looking statements contain such identifying words. All statements other than historical facts are forward looking statements. Such statements include\, but are not limited to\, statements concerning the Company’s intended use of proceeds from the exercise of its warrants for cash. Forward looking statements are based on current expectations\, estimates\, projections\, targets\, opinions and/or beliefs of the Company\, and such statements involve known and unknown risks\, uncertainties and other factors. \n\n\n\nThe risks and uncertainties that could cause those actual results to differ materially from those expressed or implied by these forward looking statements include\, but are not limited to: (a) the ability to recognize the anticipated benefits of the business combination and any transactions contemplated thereby\, which may be affected by\, among other things\, competition\, the ability of the Company to grow and manage growth profitably and retain its management and key employees; (b) the possibility that the Company may be adversely affected by other economic\, business\, and/or competitive factors; (c) the Company’s ability to develop and operate new projects; (d) the reduction or elimination of government economic incentives to the renewable energy market; (e) delays in acquisition\, financing\, construction and development of new projects; (f) the length of development cycles for new projects\, including the design and construction processes for the Company’s projects; (g) the Company’s ability to identify suitable locations for new projects; (h) the Company’s dependence on landfill operators; (i) existing regulations and changes to regulations and policies that effect the Company’s operations; (j) decline in public acceptance and support of renewable energy development and projects; (k) demand for renewable energy not being sustained; (l) impacts of climate change\, changing weather patterns and conditions\, and natural disasters; (m) the ability to secure necessary governmental and regulatory approvals; and (n) other risks and uncertainties indicated in the Registration Statement\, including those under “Risk Factors” therein\, and other documents filed or to be filed with the Securities and Exchange Commission by the Company. \n\n\n\nThe foregoing list of factors is not exclusive. You should not place undue reliance upon any forward looking statements\, which speak only as of the date made. Neither the Company nor Aria Renewable Energy Systems LLC undertakes or accepts any obligation or undertaking to update or revise the forward looking statements set forth herein\, whether as a result of new information\, future events or otherwise\, except as may be required by law. \n\n\n\n\n\n\n\nContacts\n\n\n\nInvestorsMegan Lightmlight@archaea.energy346-439-7589MediaKatarina MaticKmatic@montiethco.com917-853-1105
URL:https://commonstockwarrants.com/event/archaea-energy-inc-nyse-lfg-lfg-ws-announces-redemption-of-all-outstanding-public-warrants-begin/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/11/ARCHAEA_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211112T170000
DTEND;TZID=America/New_York:20211112T170000
DTSTAMP:20260415T182625
CREATED:20211014T054804Z
LAST-MODIFIED:20211014T054814Z
UID:692113-1636736400-1636736400@commonstockwarrants.com
SUMMARY:Janus International Group\, Inc. (NYSE: JBI\, JBI.WS) Completes Redemption of Warrants -END
DESCRIPTION:TEMPLE\, Ga.–(BUSINESS WIRE)–Janus International Group\, Inc. (NYSE: JBI) (“Janus” or the “Company”) today announced that the Company will redeem all of its outstanding warrants (the “Warrants”) to purchase shares of the Company’s common stock\, par value $0.0001 per share (the “Common Stock”)\, that were issued under the Warrant Agreement\, dated as of June 7\, 2021 by and between the Company (f/k/a Juniper Industrial Holdings\, Inc.) and Continental Stock Transfer & Trust Company (the “Warrant Agent”) and the Warrant Agreement\, dated as of July 15\, 2021\, by and between the Company and the Warrant Agent (together\, the “Warrant Agreements”)\, for a redemption price of $0.10 per Warrant (the “Redemption Price”)\, that remain outstanding at 5:00 p.m. New York City time on November 12\, 2021 (the “Redemption Date”). \n\n\n\nUnder the terms of the Warrant Agreements\, the Company is entitled to redeem all of the outstanding Warrants if the last sales price of the Common Stock has been at least $10.00 per share on the trading day prior to the date on which a notice of redemption is given. This share price performance target has been met. At the direction of the Company\, the Warrant Agent has delivered a notice of redemption to each of the registered holders of the outstanding Warrants. \n\n\n\nIn accordance with the Warrant Agreements\, upon delivery of the notice of redemption\, the Warrants may be exercised either for cash or on a “cashless basis.” Accordingly\, holders may continue to exercise Warrants and receive Common Stock in exchange for payment in cash of the $11.50 per warrant exercise price. Alternatively\, a holder may surrender Warrants for a certain number of a share of Common Stock (such fraction determined by reference to the Warrant Agreements and described in the notice of redemption) that such holder would have been entitled to receive upon a cash exercise of a Warrant. Holders of warrants that elect a “make-whole” cashless exercise of the Warrants will receive 0.3 of a share of Common Stock for each Warrant surrendered for exercise. The exercise procedures are described in the notice of redemption and the election to purchase included therein. Any Warrants that remain unexercised at 5:00 p.m. New York City time on the Redemption Date will be delisted\, void and no longer exercisable\, and the holders will have no rights with respect to those Warrants\, except to receive the Redemption Price. \n\n\n\nThe number of shares of Common Stock that each exercising warrant holder will receive by virtue of the make-whole cashless exercise (instead of paying the $11.50 per Warrant cash exercise price) was calculated in accordance with the terms of the Warrant Agreements with reference to the table set forth in Section 6.2 of the Warrant Agreements based on the fair market value of the shares of Common Stock and length of time to the applicable expiration of the Warrants. If any holder of Warrants would\, after taking into account all of such holder’s Warrants exercised at one time\, be entitled to receive a fractional interest in a share of Common Stock\, the number of shares the holder will be entitled to receive will be rounded down to the nearest whole number of shares. \n\n\n\nJanus understands from the New York Stock Exchange that November 11\, 2021\, the trading day prior to the Redemption Date\, will be the last day on which the Warrants will be traded on the New York Stock Exchange. \n\n\n\nNone of Janus\, its board of directors or employees has made or is making any representation or recommendation to any holder of the Warrants as to whether to exercise\, whether on a cash or cashless basis\, or refrain from exercising any Warrants. \n\n\n\nIssuance of the shares of Common Stock underlying the Warrants has been registered by Janus under the Securities Act of 1933\, as amended\, and is covered by a registration statement filed on Form S-1 with\, and declared effective by\, the Securities and Exchange Commission (Registration No. 333-257731). Exercise of Warrants held in “street name” should be directed through the broker of the warrant holder. In addition to the broker\, questions may also be directed to Continental Stock Transfer & Trust Company\, 1 State Street\, 30th Floor\, New York\, New York 10004\, Attention: Compliance Department\, Telephone Number (212) 509-4000 or to Morrow Sodali at (800) 662-5200 (for individuals) / (203) 658-9400 (for banks and brokerages) or by email at JBI@info.morrowsodali.com. \n\n\n\nAdditional information can be found on Janus’ Investor Relations website: https://ir.janusintl.com/. \n\n\n\nAbout Janus International Group \n\n\n\nJanus International Group\, Inc. (www.JanusIntl.com) is a leading global manufacturer and supplier of turn-key self-storage\, commercial and industrial building solutions\, including: roll-up and swing doors\, hallway systems\, re-locatable storage units and facility and door automation technologies. The Janus team operates out of several U.S. locations and six locations internationally. \n\n\n\nNo Offer or Solicitation \n\n\n\nThis communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval\, nor shall there be any sale of any securities in any state or jurisdiction in which such offer\, solicitation\, or sale would be unlawful prior to registration or qualification under the securities laws of such other jurisdiction. \n\n\n\nForward Looking Statements \n\n\n\nCertain statements in this communication may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933\, as amended\, and Section 21E of the Securities Exchange Act of 1934\, as amended. All statements other than statements of historical fact included in this communication are forward-looking statements. When used in this communication\, words such as “may\,” “should\,” “could\,” “would\,” “expect\,” “plan\,” “anticipate\,” “believe\,” “estimate\,” “continue\,” or the negative of such terms or other similar expressions\, as they relate to the management team\, identify forward-looking statements. Such forward-looking statements are based on the current beliefs of Janus’ management\, based on currently available information\, as to the outcome and timing of future events\, and involve factors\, risks\, and uncertainties that may cause actual results in future periods to differ materially from such statements. \n\n\n\nIn addition to factors previously disclosed in Janus’ reports filed with the SEC and those identified elsewhere in this communication\, the following factors\, among others\, could cause actual results to differ materially from forward-looking statements or historical performance: (i) risks of the self-storage industry; (ii) the highly competitive nature of the self-storage industry and Janus’ ability to compete therein; and (iii) the risk that the demand outlook for Janus’ products may not be as strong as anticipated. \n\n\n\nThere can be no assurance that the events\, results\, trends or guidance regarding financial outlook identified in these forward-looking statements will occur or be achieved. Forward-looking statements speak only as of the date they are made\, and Janus is not under any obligation and expressly disclaims any obligation\, to update\, alter or otherwise revise any forward-looking statement\, whether as a result of new information\, future events or otherwise\, except as required by law. This communication is not intended to be all-inclusive or to contain all the information that a person may desire in considering an investment in Janus and is not intended to form the basis of an investment decision in Janus. All subsequent written and oral forward-looking statements concerning Janus or other matters and attributable to Janus or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above and under the heading “Risk Factors” in Janus’ Quarterly Report on Form 10-Q filed with the SEC on August 10\, 2021 and in Janus’ other filings. \n\n\n\n\n\n\n\nContacts\n\n\n\nInvestor Contacts\, JanusRodny Nacier / Dan ScottIR@janusintl.com(770) 562-6399Media Contacts\, JanusBethany MorehouseMarketing Content Manager\, Janus International770-746-9576Marketing@Janusintl.comMargot Olcay\, ICRMargot.Olcay@ICRinc.com
URL:https://commonstockwarrants.com/event/janus-international-group-inc-nyse-jbi-jbi-ws-completes-redemption-of-warrants-end/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/10/JANUS_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211122T080000
DTEND;TZID=America/New_York:20211222T170000
DTSTAMP:20260415T182625
CREATED:20211123T025120Z
LAST-MODIFIED:20211124T142637Z
UID:692392-1637568000-1640192400@commonstockwarrants.com
SUMMARY:23andMe (NASDAQ: ME\, MEUSW) Announces Redemption of All Outstanding Warrants - BEGIN
DESCRIPTION:SUNNYVALE\, Calif.\, Nov. 22\, 2021 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (“23andMe”)\, a leading consumer genetics and research company\, today announced that it will redeem all of its outstanding warrants (the “Public Warrants”) to purchase shares of Class A common stock of 23andMe that were issued under the Warrant Agreement\, dated October 1\, 2020 (the “Warrant Agreement”)\, by and between 23andMe and Continental Stock Transfer & Trust Company\, as warrant agent (the “Warrant Agent”)\, as part of the units sold in the initial public offering (the “IPO”) of 23andMe\, which was formerly known as VG Acquisition Corp.\, and that remain outstanding at 5:00 p.m. New York City time on December 22\, 2021 (the “Redemption Date”) for a redemption price of $0.10 per Public Warrant. In addition\, 23andMe will redeem all of its outstanding warrants to purchase Class A common stock that were issued under the Warrant Agreement in a private placement simultaneously with the IPO (the “Private Warrants” and\, together with the Public Warrants\, the “Warrants”) on the same terms as the outstanding Public Warrants. \n\n\n\nUnder the terms of the Warrant Agreement\, 23andMe is entitled to redeem all of the outstanding Public Warrants at a redemption price of $0.10 per Public Warrant if (i) the last sales price (the “Reference Value”) of the Class A common stock equals or exceeds $10.00 per share on each of twenty trading days within any thirty-day trading period ending on the third trading day prior to the date on which a notice of redemption is given and (ii) if the Reference Value is less than $18.00 per share\, the Private Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants. At the direction of 23andMe\, the Warrant Agent has delivered a notice of redemption to each of the registered holders of the outstanding Warrants. \n\n\n\nThe Warrants may be exercised by the holders thereof until 5:00 p.m. New York City time on the Redemption Date to purchase fully paid and non-assessable shares of Class A common stock underlying such Warrants. Payment upon exercise of the Warrants may be made either (i) in cash\, at an exercise price of $11.50 per share of Class A common stock\, or (ii) on a “cashless basis\,” in which the exercising holder will receive a number of shares of Class A common stock to be determined in accordance with the terms of the Warrant Agreement and based on the Redemption Date and the volume weighted average price (the “Redemption Fair Market Value”) of the Class A common stock during the ten trading days immediately following the date on which the notice of redemption is sent to holders of Warrants. 23andMe will provide holders of the Warrants with the Redemption Fair Market Value no later than one business day after such ten-trading-day period ends. In no event will the number of shares of Class A common stock issued in connection with an exercise on a cashless basis exceed 0.361 shares of Class A common stock per Warrant. If any holder of Warrants would\, after taking into account all of such holder’s Warrants exercised at one time\, be entitled to receive a fractional interest in a share of Class A common stock\, the number of shares that the holder will be entitled to receive will be rounded down to the nearest whole number of shares. \n\n\n\nAny Warrants that remain unexercised at 5:00 p.m. New York City time on the Redemption Date will be void and no longer exercisable and the holders of those Warrants will be entitled to receive only the redemption price of $0.10 per Warrant. \n\n\n\nNone of 23andMe\, its board of directors\, or employees has made or is making any representation or recommendation to any holder of the Warrants as to whether to exercise or refrain from exercising any Warrants. \n\n\n\n23andMe has filed a registration statement on Form S-1 (Registration No. 333-257768) (the “Registration Statement”) with the Securities and Exchange Commission (“SEC”) relating to the offer and sale of the shares of Class A common stock underlying the Warrants under the Securities Act of 1933\, as amended\, which Registration Statement previously has been declared effective by the SEC. \n\n\n\nThe SEC maintains an Internet website\, www.sec.gov\, through which copies of filings that 23andMe makes with the SEC\, including the prospectus filed as part of the Registration Statement\, are available. \n\n\n\nQuestions concerning redemption and exercise of the Warrants can be directed to the Warrant Agent at [1 State Street 30th Floor\, New York\, NY 10004-1561\, by telephone at (212) 509-4000 or by email at reorg@continentalstock.com.] \n\n\n\nNo Offer or SolicitationThis press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any offer of any of 23andMe’s securities in any jurisdiction in which such offer\, solicitation\, or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. \n\n\n\nAbout 23andMeFounded in 2006 and headquartered in Sunnyvale\, California\, 23andMe is a leading consumer genetics and research company. 23andMe’s mission is to help people access\, understand\, and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple U.S. Food and Drug Administration authorizations for genetic health risk reports. 23andMe has created the world’s largest crowdsourced platform for genetic research\, with 80% of its customers electing to participate. The 23andMe research platform has generated more than 180 publications on the genetic underpinnings of a wide range of diseases\, conditions\, and traits. The platform also powers the 23andMe therapeutics group\, which is currently pursuing drug discovery programs rooted in human genetics across a spectrum of disease areas\, including oncology\, respiratory\, and cardiovascular diseases\, in addition to other therapeutic areas. More information is available at www.23andMe.com. \n\n\n\nForward-Looking StatementsThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933\, as amended\, and Section 21E of the Securities Exchange Act of 1934\, as amended\, including\, without limitation\, statements regarding expectations regarding the redemption of the Warrants. All statements\, other than statements of historical fact\, included or incorporated in this press release\, are forward-looking statements. The words “anticipate\,” “believe\,” “continue\,” “could\,” “estimate\,” “expect\,” “intends\,” “may\,” “might\,” “plan\,” “possible\,” “potential\,” “predict\,” “project\,” “should\,” “would\,” and similar expressions may identify forward-looking statements\, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained herein are based on 23andMe’s current expectations and beliefs concerning future developments and their potential effects\, but there can be no assurance that these will be as anticipated. These forward-looking statements involve a number of risks\, uncertainties (some of which are beyond the control of 23andMe)\, or other assumptions that may cause actual results or performance to differ materially from those expressed or implied by these forward-looking statements. These risks and uncertainties include\, but are not limited to\, risks related to the redemption of the Warrants\, as well as those factors described in the “Risk Factors” section and other sections of 23andMe’s most recent Quarterly Report on Form 10-Q and other current and periodic reports 23andMe files with the SEC from time to time. Investors are cautioned not to place undue reliance on any such forward-looking statements\, which speak only as of the date they are made. Except as required by law\, 23andMe does not undertake any obligation to update or revise any forward-looking statements whether as a result of new information\, future events\, or otherwise. \n\n\n\nContactsInvestor Relations Contact: investors@23andMe.comMedia Contact: press@23andMe.com
URL:https://commonstockwarrants.com/event/23andme-nasdaq-me-meusw-announces-redemption-of-all-outstanding-warrants-begin/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/11/23ANDME_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Denver:20211122T080000
DTEND;TZID=America/Denver:20211222T170000
DTSTAMP:20260415T182625
CREATED:20211123T025237Z
LAST-MODIFIED:20211124T142626Z
UID:692390-1637568000-1640192400@commonstockwarrants.com
SUMMARY:Hillman Solutions Corp. (Nasdaq: HLMN\, HLMNW) Announces Redemption of All Outstanding Warrants - BEGIN
DESCRIPTION:CINCINNATI\, Nov. 22\, 2021 (GLOBE NEWSWIRE) — Hillman Solutions Corp. (NASDAQ: HLMN)\, (“Hillman” or “the Company”)\, a leading hardware solutions company\, today announced that the Company will redeem all of its outstanding warrants (the “Public Warrants”) to purchase shares of the Company’s common stock\, par value $0.0001 per share (the “Common Stock”)\, that were issued under the Amended and Restated Warrant Agreement (the “Warrant Agreement”)\, dated November 13\, 2020\, by and between the Company and Continental Stock Transfer & Trust Company (“CST”)\, as warrant agent (the “Warrant Agent”)\, as part of the units sold in the Company’s initial public offering (the “IPO”) and that remain outstanding at 5:00 p.m. New York City time on December 22\, 2021 (the “Redemption Date”) for a redemption price of $0.10 per Public Warrant. In addition\, the Company will redeem all of its outstanding warrants to purchase Common Stock that were issued under the Warrant Agreement in a private placement simultaneously with the IPO (the “Private Warrants” and\, together with the Public Warrants\, the “Warrants”) on the same terms as the outstanding Public Warrants. \n\n\n\nUnder the terms of the Warrant Agreement\, the Company is entitled to redeem all of the outstanding Public Warrants at a redemption price of $0.10 per Public Warrant if (i) the last sales price (the “Reference Value”) of the Common Stock equals or exceeds $10.00 per share on any twenty trading days within any thirty-day trading period ending on the third trading day prior to the date on which a notice of redemption is given and (ii) if the Reference Value is less than $18.00 per share\, the Private Warrants must also concurrently be called for redemption on the same terms as the outstanding Public Warrants. At the direction of the Company\, the Warrant Agent has delivered a notice of redemption to each of the registered holders of the outstanding Warrants. \n\n\n\nThe Warrants may be exercised by the holders thereof until 5:00 p.m. New York City time on the Redemption Date to purchase fully paid and non-assessable shares of Common Stock underlying such Warrants. As the Reference Value is less than $18.00 per share\, payment upon exercise of the Warrants may be made either (i) in cash\, at an exercise price of $11.50 per share of Common Stock or (ii) on a “cashless basis” in which the exercising holder will receive a number of shares of Common Stock to be determined in accordance with the terms of the Warrant Agreement and based on the Redemption Date and the volume weighted average price (the “Fair Market Value”) of the Common Stock during the 10 trading days immediately following the date on which the notice of redemption is sent to holders of Warrants. The Company will provide holders the Fair Market Value no later than one business day after such 10-trading day period ends. In no event will the number of shares of Common Stock issued in connection with an exercise on a cashless basis exceed 0.361 shares of Common Stock per Warrant. If any holder of Warrants would\, after taking into account all of such holder’s Warrants exercised at one time\, be entitled to receive a fractional interest in a share of Common Stock\, the number of shares the holder will be entitled to receive will be rounded down to the nearest whole number of shares. \n\n\n\nAny Warrants that remain unexercised at 5:00 p.m. New York City time on the Redemption Date will be void and no longer exercisable\, and the holders of those Warrants will be entitled to receive only the redemption price of $0.10 per Warrant. \n\n\n\nNone of the Company\, its board of directors or employees has made or is making any representation or recommendation to any holder of the Warrants as to whether to exercise or refrain from exercising any Warrants. \n\n\n\nThe shares of Common Stock underlying the Warrants have been registered by the Company under the Securities Act of 1933\, as amended\, and are covered by a registration statement filed on Form S-1 with\, and declared effective by\, the Securities and Exchange Commission (Registration No. 333-258823). The SEC maintains an Internet website that contains a copy of this prospectus. The address of that site is www.sec.gov. Alternatively\, you can obtain a copy of the prospectus from the Company’s investor relations website at https://ir.hillmangroup.com/financial-information. \n\n\n\nThis press release does not and will not constitute an offer to sell\, or the solicitation of an offer to buy\, the warrants\, any shares of Hillman’s common stock\, or any other securities\, nor will there be any sale of the warrants or any such shares or other securities\, in any state or other jurisdiction in which such offer\, sale or solicitation would be unlawful. \n\n\n\nAbout Hillman Solutions Corp. \n\n\n\nFounded in 1964 and headquartered in Cincinnati\, Ohio\, Hillman is a leading North American provider of complete hardware solutions\, delivered with industry best customer service to over 40\,000 locations. Hillman designs innovative product and merchandising solutions for complex categories that deliver an outstanding customer experience to home improvement centers\, mass merchants\, national and regional hardware stores\, pet supply stores\, and OEM & Industrial customers. Leveraging a world-class distribution and sales network\, Hillman delivers a “small business” experience with “big business” efficiency. For more information on Hillman\, visit www.hillmangroup.com. \n\n\n\nForward-Looking Statements \n\n\n\nThis press release may contain “forward-looking statements” within the meaning of the federal securities law. All statements other than statements of historical fact included in this presentation are forward-looking statements made in good faith by the company and are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. The Company’s actual results may differ from their expectations\, estimates and projections and consequently\, you should not rely on these forward looking statements as predictions of future events. Words such as “expect\,” “estimate\,” “project\,” “budget\,” “forecast\,” “anticipate\,” “intend\,” “plan\,” “may\,” “will\,” “could\,” “should\,” “believes\,” “predicts\,” “potential\,” “continue\,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include\, without limitation\, the Company’s expectations with respect to future performance. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside the Company’s control and are difficult to predict. Factors that may cause such differences include\, but are not limited to: (1) unfavorable economic conditions that may affect operations\, financial condition and cash flows including inflation\, recessions\, instability in the financial markets or credit markets; (2) highly competitive markets that could adversely impact financial results (3) ability to continue to innovate with new products and services; (4) seasonality; (5) large customer concentration; (6) ability to recruit and retain qualified employees; (7) the outcome of any legal proceedings that may be instituted against the Company (8) adverse changes in currency exchange rates; (9) the impact of COVID-19 on the Company’s business; or (10) regulatory changes and potential legislation that could adversely impact financial results. The foregoing list of factors is not exclusive\, and readers should also refer to those risks that will be included under the header “Risk Factors” included in the S-1 filed on August 25\, 2021 with the Securities and Exchange Commission (“SEC”). Given these uncertainties\, current or prospective investors are cautioned not to place undue reliance on any such forward looking statements. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements in this presentation to reflect any change in its expectations or any change in events\, conditions or circumstances on which any such statement is based. All estimates of financial metrics in this presentation for fiscal 2021 and beyond are current as of the date of this press release. \n\n\n\nContact Information \n\n\n\nInvestors: \n\n\n\nVP Investor RelationsJennifer HillsJennifer.Hills@hillmangroup.com513-975-5248
URL:https://commonstockwarrants.com/event/hillman-solutions-corp-nasdaq-hlmn-hlmnw-announces-redemption-of-all-outstanding-warrants-begin/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/11/HILLMAN_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211126T080000
DTEND;TZID=America/New_York:20211227T170000
DTSTAMP:20260415T182625
CREATED:20211126T131818Z
LAST-MODIFIED:20211126T131835Z
UID:692414-1637913600-1640624400@commonstockwarrants.com
SUMMARY:Astra (NASDAQ: ASTR\, ASTRW) Announces Redemption of All Outstanding Public Warrants and Private Placement Warrants
DESCRIPTION:Alameda\, CA – November 26\, 2021 – Astra Space\, Inc. (“Astra” or the “Company”) (Nasdaq: ASTR)\, today announced that it will redeem all of its outstanding Redeemable Warrants (as defined below) to purchase shares of the Company’s Class A common stock\, par value $0.0001 per share (the “Class A common stock”)\, that were issued under the Warrant Agreement\, dated August 4\, 2020 (the “Warrant Agreement”)\, by and between the Company and Continental Stock Transfer & Trust Company\, as warrant agent and transfer agent\, as a part of units sold in the Company’s initial public offering (the “Offering”) and that remain outstanding (the “Public Warrants”) at 5:00 p.m. New York City time on December 27\, 2021\, for a redemption price of $0.10 per Redeemable Warrant (the “Redemption Price”). In addition\, the Company will redeem all of its outstanding warrants to purchase Class A common stock that were issued under the Warrant Agreement in a private placement simultaneously with the Offering (the “Private Placement Warrants” and\, together with the Public Warrants\, the “Redeemable Warrants”) on the same terms as the outstanding Public Warrants. \n\n\n\nUnder Section 6.2 of the Warrant Agreement\, the Company is entitled to redeem not less than all of the outstanding Redeemable Warrants at a Redemption Price of $0.10 per Redeemable Warrant; provided that the last reported sales price of the Class A common stock has been at least $10.00 per share on the trading day prior to the date on which notice of redemption is given; and further provided that there is an effective registration statement covering the shares of Class A common stock issuable upon exercise of the Redeemable Warrants and a current prospectus relating thereto\, available through the Redemption Date. On November 24\, 2021\, the last reported sales price of a share of the Company’s Class A common stock was $10.47. \n\n\n\nThe Redeemable Warrants may be exercised by the holders thereof until 5:00 p.m. New York City time on the Redemption Date to purchase fully paid and non-assessable shares of Class A common stock underlying such Redeemable Warrants. As permitted by the Warrant Agreement\, the holders of the Redeemable Warrants are required to exercise the Redeemable Warrantson a “cashless basis\,” such that the exercising holder will receive a number of shares of Class A common stock to be determined in accordance with the terms of Section 3.3.1(b). \n\n\n\nAlternatively\, holders of Redeemable Warrants may elect to receive\, in lieu of the Redemption Price and in lieu of exercising the Redeemable Warrants on a “cashless basis\,” 0.25226 shares of Class A common stock per Warrant\, which number of shares of Class A common stock was determined by reference to the table set forth in Section 6.2 of the Warrant Agreement. \n\n\n\nAny Redeemable Warrants that remain unexercised at 5:00 p.m. New York City time on December 27\, 2021\, will be void and no longer exercisable\, and the holders of those Redeemable Warrants will be entitled to receive only the redemption price of $0.10 per Redeemable Warrant. \n\n\n\nNone of Astra\, its board of directors or employees has made or is making any representation or recommendation to any holder of the Redeemable Warrants as to whether to exercise or refrain from exercising any Redeemable Warrants. \n\n\n\nThe shares of Class A common stock underlying the Redeemable Warrants have been registered by the Company under the Securities Act of 1933\, as amended\, and are covered by a registration statement filed on Form S-1 with\, and declared effective by\, the Securities and Exchange Commission (Registration No. 333-257930). The SEC maintains an Internet website that contains a copy of this prospectus. The address of that site is www.sec.gov. Alternatively\, you can obtain a copy of the prospectus from the Company’s investor relations website at https://investor.astra.com. \n\n\n\nQuestions concerning redemption and exercise of the Redeemable Warrants can be directed to: \n\n\n\nContinental Stock Transfer & Trust Company\, \n\n\n\n1 State Street\, 30th Floor\, \n\n\n\nNew York\, NY 10004\, \n\n\n\nAttention: Reorganization Department \n\n\n\nTelephone: (212) 509-4000 \n\n\n\nEmail: compliance@continentalstock.com \n\n\n\nFor a copy of the notice of redemption\, please visit the Company’s investor relations website at https://investor.astra.com. \n\n\n\nNo Offer or Solicitation \n\n\n\nThis press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any offer of any of Astra’s securities in any jurisdiction in which such offer\, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. \n\n\n\nAbout Astra \n\n\n\nAstra’s mission is to improve life on Earth from space by creating a healthier and more connected planet. Today\, Astra offers the one of the lowest cost-per-dedicated-orbital-launch service of any operational launch provider in the world. Astra completed its first commercial orbital launch in November 2021\, making it one of the fastest U.S. companies in history to reach this milestone. Astra is based in Alameda\, California\, and was founded in 2016. Astra (NASDAQ: ASTR) was the first space launch company to be publicly traded on Nasdaq. Visit www.astra.com to learn more about Astra. \n\n\n\nForward Looking Statements \n\n\n\nThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933\, as amended\, and Section 21E of the Securities Exchange Act of 1934\, as amended. Forward-looking statements include statements regarding future events. In some cases\, you can identify forward looking statements because they contain words such as “may\,” “will\,” “should\,” “expects\,” “plans\,” “anticipates\,” “going to\,” “can\,” “could\,” “should\,” “would\,” “intends\,” “target\,” “projects\,” “contemplates\,” “believes\,” “estimates\,” “predicts\,” “potential\,” “outlook\,” “forecast\,” “objective\,” “plan\,” “seek\,” “grow\,” “target\,” “if\,” “continue” or the negative of these words or other similar terms or expressions that concern Company’s expectations\, strategy\, priorities\, plans or intentions. These statements are subject to known and unknown risks\, uncertainties and other factors that may cause our actual results to differ materially from results expressed or implied in this press release\, including but not limited to the risks and uncertainties contained in the Risk Factors section of our Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 13\, 2021\, and Amendment No.1 of Form 10-Q filed with SEC on October 22\, 2021. \n\n\n\nThese forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside Company’s control and are difficult to predict. The forward-looking statements included in this press release speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements\, and the Company assumes no obligation\, and does not intend\, to update these forward-looking statements as a result of future events or developments. \n\n\n\nWhen the Company uses the phrase “commercial orbital launch\,” it means a launch conducted under an FAA Commercial Launch License. \n\n\n\nContact Information \n\n\n\nInvestor Contact: \n\n\n\nDane Lewis \n\n\n\ninvestors@astra.com \n\n\n\nMedia Contact: \n\n\n\nKati Dahm \n\n\n\nkati@astra.com
URL:https://commonstockwarrants.com/event/astra-nasdaq-astr-astrw-announces-redemption-of-all-outstanding-public-warrants-and-private-placement-warrants/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/11/ASTRA_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211129T080000
DTEND;TZID=America/New_York:20211227T170000
DTSTAMP:20260415T182625
CREATED:20211129T122556Z
LAST-MODIFIED:20211129T123015Z
UID:692504-1638172800-1640624400@commonstockwarrants.com
SUMMARY:Alight (NYSE: ALIT\, ALIT.WS) Announces Redemption of All Outstanding Warrants
DESCRIPTION:Alight (NYSE: ALIT) (“Alight or the “Company”)\, a leading cloud-based provider of integrated digital human capital and business solutions\, today announced that the Company will redeem all of its outstanding warrants (the “Warrants”) to purchase shares of the Company’s Class A common stock\, par value $0.0001 per share (the “Class A Common Stock”)\, that were issued under the Warrant Agreement\, dated as of May 29\, 2020\, by and between Foley Trasimene Acquisition Corp. (n/k/a Alight Group\, Inc.) (“FTAC”) and Continental Stock Transfer & Trust Company (the “Warrant Agent”)\, as amended by the Warrant Assumption Agreement\, dated as of July 2\, 2021 (together\, the “Warrant Agreement”)\, by and between the Company\, FTAC and the Warrant Agent\, for a redemption price of $0.10 per Warrant (the “Redemption Price”)\, that remain outstanding at 5:00 p.m. New York City time on December 27\, 2021 (the “Redemption Date”). \n\n\n\nRedemption Details \n\n\n\nUnder the terms of the Warrant Agreement\, the Company is entitled to redeem all of the outstanding Warrants if the Reference Value (as defined below) equals or exceeds $10.00 per share and\, if the Reference Value is less than $18.00 per share\, any Private Placement Warrants and Forward Purchase Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants (each as defined in the Warrant Agreement). “Reference Value” means the last reported sales price of the shares of Class A Common Stock for any twenty (20) trading days within the thirty (30) trading-day period ending on the third trading day prior to the date on which notice of the redemption is given. This share price performance target has been met. No Private Placement Warrants are outstanding\, and the Forward Purchase Warrants are being concurrently called for redemption on the same terms as the outstanding Public Warrants. At the direction of the Company\, the Warrant Agent delivered a notice of redemption to each of the registered holders of the outstanding Warrants on November 26\, 2021. \n\n\n\nIn accordance with the Warrant Agreement\, upon delivery of the notice of redemption\, the Warrants may be exercised either for cash or on a “cashless basis.” Accordingly\, holders may continue to exercise Warrants and receive Class A Common Stock in exchange for payment in cash of the $11.50 per warrant exercise price. Alternatively\, a holder may surrender Warrants for a certain number of shares of Class A Common Stock (such fraction determined by reference to the Warrant Agreement and described in the notice of redemption) that such holder would have been entitled to receive upon a cash exercise of a Warrant. Holders of Warrants that elect a “make-whole” cashless exercise of the Warrants will receive a number of shares of Class A Common Stock for each Warrant surrendered for exercise to be provided to the holders of Warrants no later than December 13\, 2021. The exercise procedures are described in the notice of redemption and the election to purchase included therein. Any Warrants that remain unexercised at 5:00 p.m. New York City time on the Redemption Date will be delisted\, void and no longer exercisable\, and the holders will have no rights with respect to those Warrants\, except to receive the $0.10 per Warrant. \n\n\n\nThe number of shares of Class A Common Stock that each exercising Warrant holder will receive by virtue of the make-whole cashless exercise (instead of paying the $11.50 per Warrant cash exercise price) will be calculated in accordance with the terms of the Warrant Agreements with reference to the table set forth in Section 6.2 of the Warrant Agreements based on the fair market value of the shares of Class A Common Stock and length of time to the applicable expiration of the Warrants. If any holder of Warrants would\, after taking into account all of such holder’s Warrants exercised at one time\, be entitled to receive a fractional interest in a share of Class A Common Stock\, the number of shares the holder will be entitled to receive will be rounded down to the nearest whole number of shares. \n\n\n\nAlight understands from the New York Stock Exchange that December 23\, 2021\, the trading day prior to the Redemption Date\, will be the last day on which the Warrants will be traded on the New York Stock Exchange. \n\n\n\nNone of Alight\, its board of directors or employees has made or is making any representation or recommendation to any holder of the Warrants as to whether to exercise\, whether on a cash or cashless basis\, or refrain from exercising any Warrants. \n\n\n\nIssuance of the shares of Class A Common Stock underlying the Warrants has been registered by Alight under the Securities Act of 1933\, as amended\, and is covered by a registration statement filed on Form S-1 with\, and declared effective by\, the Securities and Exchange Commission (Registration No. 333-258350). Exercise of Warrants held in “street name” should be directed through the broker of the Warrant holder. In addition to the broker\, questions may also be directed to Continental Stock Transfer & Trust Company\, 1 State Street\, 30th Floor\, New York\, New York 10004\, Attention: Compliance Department\, Telephone Number (212) 509-4000. \n\n\n\nAbout Alight Solutions \n\n\n\nWith an unwavering belief that a company’s success starts with its people\, Alight Solutions is a leading cloud-based provider of integrated digital human capital and business solutions. Leveraging proprietary AI and data analytics\, Alight optimizes business process as a service (BPaaS) to deliver superior outcomes for employees and employers across a comprehensive portfolio of services. Alight allows employees to enrich their health\, wealth and work while enabling global organizations to achieve a high-performance culture. Alight’s 15\,000 dedicated colleagues serve more than 30 million employees and family members. Learn how Alight helps organizations of all sizes\, including over 70% of the Fortune 100. \n\n\n\nFor more information\, please visit www.alight.com. \n\n\n\nNo Offer or Solicitation \n\n\n\nThis communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval\, nor shall there be any sale of any securities in any state or jurisdiction in which such offer\, solicitation\, or sale would be unlawful prior to registration or qualification under the securities laws of such other jurisdiction. \n\n\n\nForward Looking Statements \n\n\n\nThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933\, as amended (the “Securities Act”)\, and Section 21E of the Securities Exchange Act of 1934\, as amended. These statements include\, but are not limited to\, statements related to the expectations regarding the redemption of the Alight’s warrants. In some cases\, these forward-looking statements can be identified by the use of words such as “outlook\,” “believes\,” “expects\,” “potential\,” “continues\,” “may\,” “will\,” “should\,” “could\,” “seeks\,” “projects\,” “predicts\,” “intends\,” “plans\,” “estimates\,” “anticipates” or the negative version of these words or other comparable words. Such forward-looking statements are subject to various risks and uncertainties including\, among others\, risks related to the level of business activity of our clients\, risks related to the impact of the COVID-19 pandemic\, including as a result of new strains or variants of the virus\, competition in our industry\, the performance of our information technology systems and networks\, our ability to maintain the security and privacy of confidential and proprietary information and changes in regulation. Additional factors that could cause Alight’s results to differ materially from those described in the forward-looking statements can be found under the section entitled “Risk Factors” of Alight’s prospectus filed with the Securities and Exchange Commission (the “SEC”) on August 24\, 2021 pursuant to Rule 424(b)(3) under the Securities Act\, as such factors may be updated from time to time in Alight’s filings with the SEC\, which are accessible on the SEC’s website at www.sec.gov. Accordingly\, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in Alight’s filings with the SEC. Alight undertakes no obligation to publicly update or review any forward-looking statement\, whether as a result of new information\, future developments or otherwise\, except as required by law. \n\n\n\n\n\n\n\nContacts\n\n\n\nInvestors:Alight Investor Relationsinvestor.relations@alight.com \n\n\n\nMedia:MacKenzie Lucasmackenzie.lucas@alight.com
URL:https://commonstockwarrants.com/event/alight-nyse-alit-alit-ws-announces-redemption-of-all-outstanding-warrants/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/11/ALIGHT_logo.png
END:VEVENT
END:VCALENDAR